// Auto-generated by scripts/generate-researcher-theses.js on 2025-10-28T04:15:33.626Z
// Do not edit by hand. Re-run the script with updated inputs.

export const MOCK_SIMILAR_PAPERS_LIBRARY = {
  "version": 2,
  "defaultEntryId": "3",
  "entries": [
    {
      "id": "3",
      "sourcePdf": {
        "path": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "publicPath": "/mock-papers/3.pdf",
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "originalFileName": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "doi": "10.1101/2025.04.14.648850doi",
        "pages": 29
      },
      "label": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS",
      "generatedAt": "2025-10-25T03:44:22.763Z",
      "claimsAnalysis": {
        "text": "# Executive Summary **Main findings:**   1) The authors present C2S-Scale, an LLM family up to 27B parameters trained on \"cell sentences\" and text, claiming broad state-of-the-art performance across predictive, generative, and natural-language single-cell tasks. 2) Performance scales with model and data size, and reinforcement learning (GRPO) improves perturbation response prediction, including a reported 16% reduction in scFID on interferon genes. 3) A dual-context virtual screen nominates silmitasertib as an interferon-conditional amplifier of antigen presentation, validated in two human cell models with consistent MHC-I increases only in the presence of interferon.  **Headline numbers:** 95.43% cell-type annotation accuracy on an immune dataset (vs scGPT 93.1% and Geneformer 94.0%). GRPO gains: Kendall's τ +9.2% and Pearson's r +6.6% for a 410M model on L1000; τ +4.9% and r +3.6% for a 1B model; scFID on interferon-related genes -16%. Silmitasertib validation: MHC-I MFI increases of 13.6% at 10 nM and 34.9% at 1000 nM with IFN-β; 24.9% at 10 nM and 37.3% at 300 nM with IFN-γ; 17.1% at 10 nM and 28.1% at 100 nM in a second cell model.  **Overall evidence strength:** **Moderate.** The work reports consistent cross-task improvements and gives key numeric gains and wet-lab validation, but many evaluations are summarised without full statistics, several benchmarks rely on text metrics or internal datasets, and some details are confined to figures or Supplements not fully visible in the extract.  ---  # Top 3 Claims and Evidence  ## C1. C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks. **Evidence summary:** Multi-task benchmarking shows higher or comparable performance to scGPT and Geneformer on traditional single-cell tasks, plus superior natural-language interpretation and QA vs general LLMs. Example given: immune tissue dataset cell-type annotation at 95.43% accuracy, slightly better than scGPT and Geneformer. Also reports outperforming GPT-4o in natural-language QA by 3% BERTScore and leading cluster captioning and dataset-level interpretation benchmarks. Evidence type: computational benchmarking on held-out cells, clusters, datasets; language metrics (BERTScore) for text tasks.   **Key numbers:** 95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% on immune data; QA BERTScore +3% vs GPT-4o.   **Source location:** Section 2.2 and Fig. 3; Section 2.4 and Fig. 5C-E; lines detailing 95.43% and the 3% QA margin in Section 2.2.   **Strength:** **Moderate.** Assumes fair, comparable fine-tuning; exact dataset sizes, CIs, and formal statistical tests are not reported in text. Language metrics may not fully capture biological correctness.   **Assumptions/conditions:** Comparisons are as described in the text; figures not directly inspectable here. No external validation set beyond those described.  ## C2. Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions. **Evidence summary:** Scaling from 410M to 27B parameters yields consistent gains across tasks; similar trends hold for LoRA-based fine-tuning and as training data grows. For perturbation response prediction, C2S-Scale beats scGen, scGPT, and CellOT on MMD, Wasserstein, and scFID. GRPO with biologically targeted rewards improves L1000 and cytokine-stimulation tasks, including a 16% scFID reduction on interferon-related genes. Evidence type: computational scaling studies and held-out perturbation benchmarks; embedding-space distributional metrics; RL ablations.   **Key numbers:** Parameter range 410M to 27B; scFID on interferon-related genes -16% with GRPO; L1000 gains: Kendall's τ +9.2% and Pearson's r +6.6% for 410M, τ +4.9% and r +3.6% for 1B; outperforms baselines across MMD, Wasserstein, scFID.   **Source location:** Section 2.3 and Fig. 4C-E; Section 2.7 and Fig. 8E-G.   **Strength:** **Moderate.** Clear directional effects with specific improvements reported, but full numeric baselines, confidence intervals, and dataset sizes per metric are not provided in text.   **Assumptions/conditions:** Benchmarks and metrics are as summarised; scFID uses scGPT embeddings; task mixes are comparable between models.  ## C3. A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models. **Evidence summary:** Dual-context in-silico screen predicted a context split for silmitasertib, with strong MHC-I increases only under low-level interferon signalling. Interferon activity in screen contexts differed strongly (****, P < 0.0001, Wilcoxon). Wet-lab validation showed no effect of silmitasertib alone but marked HLA-A,B,C surface increases with low-dose IFN-β and IFN-γ in Merkel-origin cells, replicated in a pulmonary model. Evidence type: computational prediction followed by experimental validation with flow cytometry.   **Key numbers:** IFN context difference: ****, P < 0.0001. Merkel model with IFN-β: MHC-I MFI +13.6% at 10 nM, +34.9% at 1000 nM. With IFN-γ: +24.9% at 10 nM, +37.3% at 300 nM. Pulmonary model: +17.1% at 10 nM and +28.1% at 100 nM. n = 3 independent experiments; two-sided tests with multiple-comparison correction.   **Source location:** Section 2.8 and Fig. 9B-H; Methods 4.8-4.9.   **Strength:** **Moderate.** Replicated across two models with coherent dose responses, but small n, absence of exact p-values for MFI changes in text, and limited cell-type diversity.   **Assumptions/conditions:** The IFN-conditional effect is defined by increases in MHC-I MFI under stated IFN doses; training did not include these cell models.  ---  # Gaps & Limitations (linked to C1-C3) - **Benchmark transparency and statistics (C1, C2):** Many results are summarised without full sample sizes, confidence intervals, or p-values in text. Several outcomes rely on BERTScore rather than biological ground truth for text tasks. Source: Sections 2.2, 2.4; Fig. 3, Fig. 5.   - **Potential evaluation bias and metric dependence (C2):** scFID depends on embeddings from another model (scGPT), which may bias comparisons. Distributional metrics are reported without detailed uncertainty. Source: Section 2.7 and 4.7; Fig. 8E-G.   - **Small-scale wet-lab validation (C3):** n = 3 experiments per condition, two cell models only, no in vivo validation, and no exact p-values for MFI changes in text. Source: Section 2.8; Fig. 9F-H; Methods 4.9.   - **Model architecture caveats and hallucination risk (C1, C2):** Authors note unidirectional causal attention limitations and LLM hallucinations for open-ended tasks. Source: Supplementary 7.1.1-7.1.2.   - **OCR/visibility constraints:** Figures and tables are referenced but not viewable here; some spacing artefacts in numbers and units are present [UNCLEAR].  ---  # Methods Snapshot - **Design:** Develop LLMs that encode scRNA-seq profiles as ranked \"cell sentences\" and jointly train on multimodal corpus with text and metadata. Two-phase training: large-scale self-supervision plus task-specific fine-tuning, with optional GRPO reinforcement learning. Introduces scFID for generative evaluation.   - **Data:** >50 million human and mouse single cells from CELLxGENE and Human Cell Atlas with associated text; additional datasets for tasks including CosMx liver spatial data, Dong et al. cytokine perturbations, and L1000 bulk landmark genes. Source: Sections 2.1, 4.1-4.3, 4.6-4.8.   - **Models:** Decoder-only Transformer backbones up to 27B parameters; input is tokenised gene names with positional encodings preserving rank order; LoRA used for parameter-efficient tuning. Source: Sections 2.1, 4.3-4.5.   - **Analyses:** Benchmarks across classification, generation, embedding, spatial reasoning, NL interpretation, QA, and perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID. Source: Sections 2.2-2.7; 4.4-4.7.  ---  # Risk-of-Bias and Quality Checklist - **Clear primary outcomes and metrics specified:** Partially. Several metrics named, but full numeric details often in figures or Supplement.   - **Comparators appropriate and described:** Yes, named baselines include scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o, etc., but configuration details are brief.   - **Train-test separation and OOD tests:** Claimed for several tasks, including unseen studies and perturbations. Details are summarised, not fully enumerated.   - **Statistical reporting:** Limited in text; few confidence intervals or exact p-values beyond the **** P < 0.0001 IFN context contrast.   - **External validation:** Wet-lab validation for one discovery across two cell models; broader external validations not reported in text.   - **Risk of leakage or overfitting controls:** Not fully detailed; authors note held-out partitions and OOD sets; some training data used to generate language targets with GPT models.   - **Limitations acknowledged by authors:** Yes, causal attention constraints and hallucination risks.   Overall quality: **Moderate**, chiefly due to summarised reporting and reliance on internal metrics without full statistical detail in the text.  ---  # Open Questions and Next Steps 1) **Generalisation of IFN-conditional amplification:** Test silmitasertib across additional tissues, primary cells, and IFN dose-response curves, including mechanistic assays for CK2-STAT1/IRF1 pathway modulation. Source link: Section 2.8; Fig. 9E-H.   2) **Robustness of scFID and embedding-metric conclusions:** Compare scFID using alternative embedding models and report variance and CIs to assess metric sensitivity. Source: Sections 2.7, 4.7.   3) **Benchmark transparency:** Release full per-task numeric tables with N, effect sizes, and uncertainty; include pre-registered evaluation splits. Source: Sections 2.2-2.7; Fig. 3-6, 8.   4) **Mitigating hallucination in NL tasks:** Add constrained decoding or fact-checking against curated gene and pathway KBs for dataset interpretation and cluster captioning. Source: Supplementary 7.1.2.   5) **Architectural exploration:** Evaluate hybrid attention or order-invariance strategies to address causal attention limitations and quantify gains on biologically causal tasks. Source: Supplementary 7.1.1.  ---  ## QA Check - All required sections present.   - Numbers match the provided text exactly.   - Each of C1-C3 includes a strength rating and specific source locations.   - Missing figure values are acknowledged where precise numbers are not visible.",
        "structured": {
          "executiveSummary": [
            "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" and text shows broad state-of-the-art performance across predictive, generative, and natural-language tasks.",
            "Scaling and GRPO improve performance; reported scFID -16% on interferon genes; L1000 gains in Kendall's τ and Pearson's r.",
            "Virtual screen plus wet-lab validation identifies silmitasertib as an interferon-conditional amplifier of antigen presentation.",
            "Overall evidence strength: Moderate."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "evidenceSummary": "Multi-task benchmarking on held-out single-cell tasks and natural-language interpretation shows higher or comparable performance to scGPT and Geneformer, and improved NL interpretation and QA vs general LLMs; example immune dataset cell-type annotation reaches 95.43% accuracy.",
              "keyNumbers": [
                "95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% (immune dataset)",
                "QA BERTScore +3% vs GPT-4o"
              ],
              "source": "Section 2.2; Fig. 3. Section 2.4; Fig. 5C-E.",
              "strength": "Moderate",
              "assumptions": "Assumes comparable fine-tuning and evaluation across models; figures not directly inspectable; language metrics may not fully reflect biological correctness.",
              "evidenceType": "Computational benchmarking on held-out datasets (classification, generation, NL interpretation, QA)."
            },
            {
              "id": "C2",
              "claim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "evidenceSummary": "Performance improves from 410M to 27B parameters and with more data; LoRA shows similar trends. Perturbation prediction benchmarks show superiority over scGen, scGPT, CellOT on MMD, Wasserstein, scFID; GRPO yields a 16% scFID reduction on interferon genes and gains on L1000.",
              "keyNumbers": [
                "Model size: 410M-27B",
                "scFID on interferon-related genes -16% with GRPO",
                "L1000: Kendall's τ +9.2% and Pearson's r +6.6% (410M)",
                "L1000: Kendall's τ +4.9% and Pearson's r +3.6% (1B)"
              ],
              "source": "Section 2.3; Fig. 4C-E. Section 2.7; Fig. 8E-G.",
              "strength": "Moderate",
              "assumptions": "scFID computed in scGPT embedding space; baselines and task mixes as summarised.",
              "evidenceType": "Computational scaling study and perturbation benchmarks with RL ablations."
            },
            {
              "id": "C3",
              "claim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "evidenceSummary": "Dual-context screen predicts strong MHC-I increases only under low-level interferon signalling; IFN activity differs significantly across contexts. Flow cytometry shows no effect of silmitasertib alone but marked HLA-A,B,C increases with low-dose IFN-β and IFN-γ in a Merkel-origin model, replicated in a pulmonary model.",
              "keyNumbers": [
                "IFN context difference: ****, P < 0.0001 (Wilcoxon)",
                "Merkel model + IFN-β: MHC-I MFI +13.6% (10 nM), +34.9% (1000 nM)",
                "Merkel model + IFN-γ: +24.9% (10 nM), +37.3% (300 nM)",
                "Pulmonary model: +17.1% (10 nM), +28.1% (100 nM)",
                "n = 3 independent experiments; two-sided tests with multiple-comparison correction"
              ],
              "source": "Section 2.8; Fig. 9B-H. Methods 4.8-4.9.",
              "strength": "Moderate",
              "assumptions": "IFN-conditional effect defined by MHC-I MFI increases under stated IFN doses; cell models were unseen during training.",
              "evidenceType": "Computational virtual screening plus experimental validation (flow cytometry)."
            }
          ],
          "gaps": [
            {
              "category": "Benchmark transparency and statistics",
              "detail": "Results often summarised without full Ns, confidence intervals, or p-values; reliance on BERTScore for some tasks.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Metric dependence and potential bias",
              "detail": "scFID depends on scGPT embeddings; uncertainty estimates not provided.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Wet-lab validation scope",
              "detail": "Small n (3), two cell models, no in vivo validation; exact p-values for MFI changes not reported in text.",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Model limitations and hallucination risk",
              "detail": "Causal attention unidirectionality and LLM hallucinations noted by authors.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Figure/text visibility",
              "detail": "Figures referenced but not viewable here; possible OCR artefacts [UNCLEAR].",
              "relatedClaimIds": [
                "C1",
                "C2",
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Develop decoder-only LLMs that encode scRNA-seq as ranked \"cell sentences\", trained on a multimodal corpus with text and metadata.",
            "Two-phase training: large-scale self-supervision plus task-specific fine-tuning; optional GRPO reinforcement learning.",
            "Data include >50M cells (CELLxGENE, HCA) and task-specific datasets (CosMx liver spatial, Dong et al., L1000).",
            "Analyses span classification, generation, embedding, spatial reasoning, NL interpretation, QA, perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID."
          ],
          "riskChecklist": [
            {
              "item": "Clear primary outcomes and metrics specified",
              "status": "partial",
              "note": "Metrics named, but many numeric details only in figures/Supplement."
            },
            {
              "item": "Comparators appropriate and described",
              "status": "met",
              "note": "Baselines named (scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o)."
            },
            {
              "item": "Train-test separation and OOD tests",
              "status": "partial",
              "note": "Held-out and OOD described, but details summarised."
            },
            {
              "item": "Statistical reporting",
              "status": "missing",
              "note": "Few CIs or exact p-values reported in text beyond IFN context comparison."
            },
            {
              "item": "External validation",
              "status": "partial",
              "note": "Wet-lab validation for one discovery in two cell models."
            },
            {
              "item": "Risk of leakage or overfitting controls",
              "status": "unclear",
              "note": "Not fully detailed; some prompts/targets involve GPT-generated text."
            },
            {
              "item": "Limitations acknowledged by authors",
              "status": "met",
              "note": "Causal attention and hallucination risks noted."
            }
          ],
          "openQuestions": [
            "Generalisation of IFN-conditional amplification: test silmitasertib across more tissues and IFN dose-responses; probe CK2-STAT1/IRF1 mechanisms.",
            "Robustness of scFID: evaluate alternative embedding models and report variance/CIs.",
            "Benchmark transparency: release per-task tables with N, effect sizes, uncertainty and pre-registered splits.",
            "Mitigating hallucination in NL tasks: add constrained decoding or biological fact-checking.",
            "Architectural exploration: test hybrid attention or order-invariance to address causal attention limits."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T21:49:02.191Z",
      "updatedAt": "2025-10-27T20:42:33.510Z",
      "agent": {
        "maxChars": 10579,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "summary": "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" plus text shows broad SOTA across predictive, generative, and natural-language single-cell tasks; scaling and GRPO improve perturbation prediction; a virtual screen with wet-lab validation identifies silmitasertib as an interferon-conditional MHC-I amplifier.",
        "keyMethodSignals": [
          "Decoder-only Transformers on ranked gene-token \"cell sentences\" with text",
          "Two-phase training with task-specific fine-tuning and optional GRPO",
          "Benchmarks across annotation, generation, embedding, spatial reasoning, NL QA",
          "Metrics include BERTScore, MMD, Wasserstein, and scFID",
          "Virtual screen followed by flow-cytometry validation under IFN context"
        ],
        "methodComparison": {
          "sample": ">50 million cells from CELLxGENE and HCA, plus task-specific sets (CosMx liver spatial, cytokine perturbations, L1000).",
          "materials": "Decoder-only LLMs up to 27B; LoRA variants; multimodal corpus combining \"cell sentences\" and text; GRPO for perturbation tasks; compounds including silmitasertib.",
          "equipment": "GPU clusters for training and fine-tuning; flow cytometer for HLA-A,B,C surface assays with IFN-β or IFN-γ.",
          "procedure": "Self-supervised pretraining on \"cell sentences\" followed by task-specific fine-tuning; optional GRPO; multi-task benchmarking; dual-context virtual screen and targeted flow-cytometry validation.",
          "outcomes": "SOTA or parity vs scGPT/Geneformer; scaling gains 410M→27B; GRPO boosts L1000 τ and r and reduces interferon-gene scFID by 16 percent; silmitasertib increases MHC-I only with low-dose IFN."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1038/s41592-024-02201-0",
          "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
          "authors": [
            "Cui et al."
          ],
          "year": 2024,
          "venue": "Nature Methods",
          "whyRelevant": "Foundation Transformer trained on tens of millions of single cells across tasks. Directly comparable baselines and datasets overlap the brief.",
          "methodOverlap": [
            "Large-scale pretraining on CELLxGENE Census cells",
            "Perturbation prediction with CRISPR Perturb-seq datasets",
            "Multi-task benchmarks including annotation and integration"
          ],
          "methodComparison": {
            "sample": "33M+ cells for pretraining; multiple public evaluation sets including PBMC multiome and CRISPR Perturb-seq.",
            "materials": "Generative pretrained Transformer; public code and processed datasets.",
            "equipment": "GPU compute; standard single-cell preprocessing pipelines for dataset preparation.",
            "procedure": "Domain pretraining on cells, then task-specific fine-tuning across annotation, perturbation, integration and GRN analysis.",
            "outcomes": "SOTA or competitive results across tasks; public splits and data release."
          },
          "gaps": "Reporting is figure-heavy; several details are in Supplement. Perturbation metrics emphasise correlations and MMD-style distances rather than scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2310.01436",
          "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
          "authors": [
            "Gong et al."
          ],
          "venue": "NeurIPS",
          "whyRelevant": "Pretrained Transformer for scRNA-seq with masking on gene tokens. Reports scaling behaviour and strong perturbation prediction performance.",
          "methodOverlap": [
            "Asymmetric encoder-decoder Transformer for sparse scRNA-seq",
            "Pretrained on large gene-token corpus with masking",
            "Downstream tasks include perturbation and drug prediction"
          ],
          "methodComparison": {
            "sample": "Curated multi-study scRNA-seq spanning ~19,264 genes and a large token corpus.",
            "materials": "Auto-discretised value embeddings with gene-token embeddings; masking regression objective.",
            "equipment": "GPU compute; no wet-lab components.",
            "procedure": "Pretrain with biased masking on non-zeros; fine-tune for annotation, perturb-seq and drug tasks.",
            "outcomes": "Scaling improves accuracy; SOTA or competitive on annotation and perturbation prediction."
          },
          "gaps": "Limited disclosure of per-task Ns and uncertainty. Evaluation emphasises accuracy and correlation without generative distributional scores like scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2210.14330",
          "title": "A single-cell gene expression language model (Exceiver)",
          "authors": [
            "Connell",
            "Khan",
            "Keiser"
          ],
          "year": 2022,
          "venue": "NeurIPS Workshop",
          "whyRelevant": "Language-model framing with masking and set-like tokenisation. Explores order-invariant design relevant to causal-attention ordering caveat.",
          "methodOverlap": [
            "Self-supervised masking over gene tokens and counts",
            "Perceiver-IO to handle unordered, long gene inputs",
            "Transfer learning to downstream classification tasks"
          ],
          "methodComparison": {
            "sample": "Pretrained on Tabula Sapiens (~500k cells, 24 organs) with a 70/30 split.",
            "materials": "Learnable gene embeddings scaled by counts; discrete-noise masking objective.",
            "equipment": "GPU compute; open-source codebase.",
            "procedure": "Self-supervised regression masking with optional tissue label; evaluate on new datasets and prediction tasks.",
            "outcomes": "Latent representations align with tissues; transfer improves downstream accuracy."
          },
          "gaps": "Smaller scale than 27B-class models; limited perturbation evaluation and no RL. Uncertainty quantification is minimal.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-023-01969-x",
          "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
          "authors": [
            "Bunne et al."
          ],
          "year": 2023,
          "venue": "Nature Methods",
          "whyRelevant": "Direct comparator for perturbation prediction with distributional metrics. Uses unpaired mapping of control to treated single-cell states.",
          "methodOverlap": [
            "Predicts perturbation effects from unpaired single-cell data",
            "Benchmarks with MMD and correlation against scGen",
            "Evaluates scRNA-seq and 4i multiplexed proteomics"
          ],
          "methodComparison": {
            "sample": "Melanoma cell-line multiplexed proteomics and scRNA-seq drug panels; patient biopsies and cross-species LPS.",
            "materials": "Input-convex neural networks parameterise optimal transport potentials.",
            "equipment": "scRNA-seq and multiplexed imaging datasets; GPU training.",
            "procedure": "Learn OT maps per perturbation from control to treated distributions; test OOD on new patients and species.",
            "outcomes": "Outperforms scGen and others on MMD and r²; captures higher moments of treated distributions."
          },
          "gaps": "Not an LLM and relies on latent autoencoder features. Distributional improvements reported without comprehensive uncertainty bands.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-019-0494-8",
          "title": "scGen predicts single-cell perturbation responses",
          "authors": [
            "Lotfollahi",
            "Wolf",
            "Theis"
          ],
          "year": 2019,
          "venue": "Nature Methods",
          "whyRelevant": "Canonical perturbation-prediction baseline with VAE latent vector arithmetic. Demonstrates cross-study and cross-species generalisation.",
          "methodOverlap": [
            "VAE latent-space shifts to model perturbations",
            "Cross-study and cross-species OOD tests",
            "Public code and reproducibility repository"
          ],
          "methodComparison": {
            "sample": "Multiple scRNA-seq datasets across tissues and species, including infection and drug responses.",
            "materials": "Variational autoencoder with linear latent manipulations; public code and reproducibility resources.",
            "equipment": "Standard single-cell sequencing datasets; GPU training.",
            "procedure": "Train VAE, infer perturbation via latent vector arithmetic; evaluate across studies and species.",
            "outcomes": "Accurate out-of-sample predictions and batch integration capabilities."
          },
          "gaps": "Linear latent shifts can miss complex distributional changes. Uncertainty reporting is limited in the original work.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "authorContacts": {
        "maxChars": 2002,
        "truncated": false,
        "text": "Paper: Scaling Large Language Models for Next-Generation Single-Cell Analysis (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Syed Asad Rizvi | syed.rizvi@yale.edu | PhD Student, Yale University, Computer Science | Not found |\n| David van Dijk | Not found | Faculty, Yale School of Medicine; Corresponding author on this paper | 0000-0003-3911-9925 |\n\nPaper: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Haotian Cui | Not found | Not found | 0000-0001-8119-9485 |\n| Bo Wang | bo.wang@uhn.ca | Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate | 0000-0002-9620-3413 |\n\nPaper: xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Jing Gong | gongjing@biomap.com | Researcher, BioMap Research (per author affiliations) | Not found |\n| Le Song | songle@biomap.com | Professor, MBZUAI; CTO, GenBio AI | 0000-0003-0345-9899 |\n| Xingyi Cheng | xingyi@biomap.com | Principal Researcher, BioMap (per OpenReview profile) | 0009-0002-6403-048X |\n\nPaper: A single-cell gene expression language model (Exceiver)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| William Connell | Not found | Graduate researcher, Keiser Lab, UCSF (per lab page) | Not found |\n| Michael J. Keiser | Not found | Not found | Not found |\n\nPaper: Learning single-cell perturbation responses using neural optimal transport (CellOT)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Charlotte Bunne | Not found | Not found | Not found |\n| Gunnar Rätsch | gunnar.raetsch@inf.ethz.ch | Not found | Not found |\n\nPaper: scGen predicts single-cell perturbation responses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Mohammad Lotfollahi | Not found | Not found | 0000-0001-6858-7985 |\n| Fabian J. Theis | Not found | Not found | 0000-0002-2419-1943 |",
        "structured": {
          "papers": [
            {
              "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Syed Asad Rizvi",
                  "email": "syed.rizvi@yale.edu",
                  "role": "PhD Student, Yale University, Computer Science",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=3nspJ4QAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://syedarizvi.com"
                    }
                  ]
                },
                {
                  "name": "David van Dijk",
                  "email": null,
                  "role": "Faculty, Yale School of Medicine; Corresponding author on this paper",
                  "orcid": "0000-0003-3911-9925",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://vandijklab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
              "identifier": null,
              "authors": [
                {
                  "name": "Haotian Cui",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-8119-9485",
                  "profiles": []
                },
                {
                  "name": "Bo Wang",
                  "email": "bo.wang@uhn.ca",
                  "role": "Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate",
                  "orcid": "0000-0002-9620-3413",
                  "profiles": []
                }
              ]
            },
            {
              "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
              "identifier": null,
              "authors": [
                {
                  "name": "Jing Gong",
                  "email": "gongjing@biomap.com",
                  "role": "Researcher, BioMap Research (per author affiliations)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Le Song",
                  "email": "songle@biomap.com",
                  "role": "Professor, MBZUAI; CTO, GenBio AI",
                  "orcid": "0000-0003-0345-9899",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=OQqQLbMAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://dasongle.github.io"
                    }
                  ]
                },
                {
                  "name": "Xingyi Cheng",
                  "email": "xingyi@biomap.com",
                  "role": "Principal Researcher, BioMap (per OpenReview profile)",
                  "orcid": "0009-0002-6403-048X",
                  "profiles": []
                }
              ]
            },
            {
              "title": "A single-cell gene expression language model (Exceiver)",
              "identifier": null,
              "authors": [
                {
                  "name": "William Connell",
                  "email": null,
                  "role": "Graduate researcher, Keiser Lab, UCSF (per lab page)",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://wconnell.github.io/research"
                    }
                  ]
                },
                {
                  "name": "Michael J. Keiser",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://keiserlab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
              "identifier": null,
              "authors": [
                {
                  "name": "Charlotte Bunne",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gunnar Rätsch",
                  "email": "gunnar.raetsch@inf.ethz.ch",
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "scGen predicts single-cell perturbation responses",
              "identifier": null,
              "authors": [
                {
                  "name": "Mohammad Lotfollahi",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-6858-7985",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://m0hammadl.github.io/publication/scgen"
                    }
                  ]
                },
                {
                  "name": "Fabian J. Theis",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0002-2419-1943",
                  "profiles": []
                }
              ]
            }
          ],
          "promptNotes": "Converted strictly from analyst notes. Unknown fields set to null."
        }
      },
      "researcherTheses": {
        "maxChars": 6053,
        "truncated": false,
        "text": "Researcher: Syed Asad Rizvi\nEmail: [syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: BrainLM: A foundation model for brain activity recordings\n  - Year: 2024\n  - Venue: ICLR 2024\n  - URL: https://openreview.net/pdf?id=RwI7ZEfR27\nPhD thesis: Not found\n\nResearcher: David van Dijk\nEmail: [david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: Intelligence at the Edge of Chaos\n  - Year: 2025\n  - Venue: ICLR 2025\n  - URL: https://arxiv.org/abs/2410.02536\nPhD thesis:\n  - Title: The Symphony of Gene Regulation\n  - Year: 2013\n  - Institution: University of Amsterdam\n  - URL: https://pure.uva.nl/ws/files/1692458/126481_02.pdf\n\nResearcher: Haotian Cui\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Foundation Model for Single-Cell Omics\n  - Year: 2024\n  - Institution: University of Toronto\n  - URL: https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full\n\nResearcher: Bo Wang\nEmail: [bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning\n  - Year: 2017\n  - Institution: Stanford University\n  - URL: https://purl.stanford.edu/cc855fh0112\n\nResearcher: Jing Gong\nEmail: [gongjing@biomap.com](mailto:gongjing@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis:\n  - Title: RNA二级结构及相互作用的计算方法和功能研究\n  - Year: 2020\n  - Institution: Tsinghua University, School of Life Sciences\n  - URL: https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093\n\nResearcher: Le Song\nEmail: [songle@biomap.com](mailto:songle@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: Xingyi Cheng\nEmail: [xingyi@biomap.com](mailto:xingyi@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: William Thomas Connell\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning chemical sensitivity reveals mechanisms of cellular response\n  - Year: 2024\n  - Venue: Communications Biology\n  - URL: https://www.nature.com/articles/s42003-024-06865-4.pdf\nPhD thesis:\n  - Title: Learning Chemical Sensitivity to Understand Disease Mechanisms\n  - Year: 2022\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/0321d4q3\n\nResearcher: Michael James Keiser\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds\n  - Year: 2024\n  - Venue: Journal of Chemical Information and Modeling\n  - URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683\nPhD thesis:\n  - Title: Relating protein pharmacology by ligand chemistry\n  - Year: 2009\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/5vp5h8g4\n\nResearcher: Charlotte Bunne\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning single-cell perturbation responses using neural optimal transport\n  - Year: 2023\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-023-01969-x.pdf\nPhD thesis:\n  - Title: Neural Optimal Transport for Dynamical Systems\n  - Year: 2023\n  - Institution: ETH Zürich\n  - URL: https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf\n\nResearcher: Gunnar Rätsch\nEmail: [gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)\nData publicly available: yes\nLatest publication:\n  - Title: Efficient and accurate search in petabase-scale sequence repositories\n  - Year: 2025\n  - Venue: Nature\n  - URL: https://www.nature.com/articles/s41586-025-09603-w.pdf\nPhD thesis:\n  - Title: Robust Boosting via Convex Optimization: Theory and Applications\n  - Year: 2001\n  - Institution: Universität Potsdam\n  - URL: https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf\n\nResearcher: Mohammad Lotfollahi\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Toward learning a foundational representation of cells and genes\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02367-7.pdf\nPhD thesis:\n  - Title: Modeling single-cell perturbations using deep learning\n  - Year: 2022\n  - Institution: Technical University of Munich (TUM), School of Life Sciences\n  - URL: https://mediatum.ub.tum.de/1631269\n\nResearcher: Fabian J. Theis\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://doi.org/10.1038/s41592-023-01994-w\nPhD thesis:\n  - Title: Geometric Source Separation: Algorithms and Applications\n  - Year: 2003\n  - Institution: Universidad de Granada\n  - URL: https://d-nb.info/1174513586",
        "structured": {
          "researchers": [
            {
              "name": "Syed Asad Rizvi",
              "email": "[syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)",
              "latest_publication": {
                "title": "BrainLM: A foundation model for brain activity recordings",
                "year": 2024,
                "venue": "ICLR 2024",
                "url": "https://openreview.net/pdf?id=RwI7ZEfR27"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "David van Dijk",
              "email": "[david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)",
              "latest_publication": {
                "title": "Intelligence at the Edge of Chaos",
                "year": 2025,
                "venue": "ICLR 2025",
                "url": "https://arxiv.org/abs/2410.02536"
              },
              "phd_thesis": {
                "title": "The Symphony of Gene Regulation",
                "year": 2013,
                "institution": "University of Amsterdam",
                "url": "https://pure.uva.nl/ws/files/1692458/126481_02.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Haotian Cui",
              "email": null,
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Foundation Model for Single-Cell Omics",
                "year": 2024,
                "institution": "University of Toronto",
                "url": "https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Bo Wang",
              "email": "[bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)",
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning",
                "year": 2017,
                "institution": "Stanford University",
                "url": "https://purl.stanford.edu/cc855fh0112"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Jing Gong",
              "email": "[gongjing@biomap.com](mailto:gongjing@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": {
                "title": "RNA二级结构及相互作用的计算方法和功能研究",
                "year": 2020,
                "institution": "Tsinghua University, School of Life Sciences",
                "url": "https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Le Song",
              "email": "[songle@biomap.com](mailto:songle@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Xingyi Cheng",
              "email": "[xingyi@biomap.com](mailto:xingyi@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "William Thomas Connell",
              "email": null,
              "latest_publication": {
                "title": "Learning chemical sensitivity reveals mechanisms of cellular response",
                "year": 2024,
                "venue": "Communications Biology",
                "url": "https://www.nature.com/articles/s42003-024-06865-4.pdf"
              },
              "phd_thesis": {
                "title": "Learning Chemical Sensitivity to Understand Disease Mechanisms",
                "year": 2022,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/0321d4q3"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Michael James Keiser",
              "email": null,
              "latest_publication": {
                "title": "Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds",
                "year": 2024,
                "venue": "Journal of Chemical Information and Modeling",
                "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683"
              },
              "phd_thesis": {
                "title": "Relating protein pharmacology by ligand chemistry",
                "year": 2009,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/5vp5h8g4"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Charlotte Bunne",
              "email": null,
              "latest_publication": {
                "title": "Learning single-cell perturbation responses using neural optimal transport",
                "year": 2023,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-023-01969-x.pdf"
              },
              "phd_thesis": {
                "title": "Neural Optimal Transport for Dynamical Systems",
                "year": 2023,
                "institution": "ETH Zürich",
                "url": "https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gunnar Rätsch",
              "email": "[gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)",
              "latest_publication": {
                "title": "Efficient and accurate search in petabase-scale sequence repositories",
                "year": 2025,
                "venue": "Nature",
                "url": "https://www.nature.com/articles/s41586-025-09603-w.pdf"
              },
              "phd_thesis": {
                "title": "Robust Boosting via Convex Optimization: Theory and Applications",
                "year": 2001,
                "institution": "Universität Potsdam",
                "url": "https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Mohammad Lotfollahi",
              "email": null,
              "latest_publication": {
                "title": "Toward learning a foundational representation of cells and genes",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02367-7.pdf"
              },
              "phd_thesis": {
                "title": "Modeling single-cell perturbations using deep learning",
                "year": 2022,
                "institution": "Technical University of Munich (TUM), School of Life Sciences",
                "url": "https://mediatum.ub.tum.de/1631269"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Fabian J. Theis",
              "email": null,
              "latest_publication": {
                "title": "Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://doi.org/10.1038/s41592-023-01994-w"
              },
              "phd_thesis": {
                "title": "Geometric Source Separation: Algorithms and Applications",
                "year": 2003,
                "institution": "Universidad de Granada",
                "url": "https://d-nb.info/1174513586"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": "Compiled from all thesis discovery responses in this thread."
        }
      },
      "patents": {
        "text": "Patent: US20240386990A1\nTitle: Predicting cellular responses to perturbations\nAssignee: Insitro Inc\nFiling Date: 2024-05-17\nGrant Date: Not provided\nAbstract: Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.\nOverlaps with paper claims: C2\nTechnical overlap: The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction.\n\nPatent: US20240203531A1\nTitle: Cell type annotation\nAssignee: Illumina Inc (current); Fluent Biosciences Inc (original)\nFiling Date: 2023-12-19\nGrant Date: Not provided\nAbstract: Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.\nOverlaps with paper claims: C1\nTechnical overlap: The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain.\n\nPatent: WO2016050203A1\nTitle: Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.\nOverlaps with paper claims: C3\nTechnical overlap: By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results.\n\nPatent: WO2017070137A1\nTitle: Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.\nOverlaps with paper claims: C3\nTechnical overlap: The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies.\n\nPatent: US10227344B2\nTitle: CK2 inhibitors, compositions and methods thereof\nAssignee: Polaris Pharmaceuticals, Inc.\nFiling Date: Not provided\nGrant Date: 2019-03-12\nAbstract: Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.\nOverlaps with paper claims: C3\nTechnical overlap: The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US20240386990A1",
              "title": "Predicting cellular responses to perturbations",
              "assignee": "Insitro Inc",
              "filingDate": "2024-05-17",
              "grantDate": null,
              "abstract": "Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction."
              },
              "url": null
            },
            {
              "patentNumber": "US20240203531A1",
              "title": "Cell type annotation",
              "assignee": "Illumina Inc (current); Fluent Biosciences Inc (original)",
              "filingDate": "2023-12-19",
              "grantDate": null,
              "abstract": "Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain."
              },
              "url": null
            },
            {
              "patentNumber": "WO2016050203A1",
              "title": "Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017070137A1",
              "title": "Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies."
              },
              "url": null
            },
            {
              "patentNumber": "US10227344B2",
              "title": "CK2 inhibitors, compositions and methods thereof",
              "assignee": "Polaris Pharmaceuticals, Inc.",
              "filingDate": null,
              "grantDate": "2019-03-12",
              "abstract": "Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; unknown fields set to null; URLs standardised to Google Patents."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nAcross claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n    Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation.\n  - [Similar Paper] A single-cell gene expression language model (Exceiver)\n    Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent.\n  - [Research Group] Cell2Sentence GitHub repository\n    Implementation and resources released, enabling some level of reproducibility.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale.\n\nSummary: The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.\n\nClaim: C2\nOriginal: Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component.\n  - [Similar Paper] scGen predicts single-cell perturbation responses\n    Provides a canonical perturbation-prediction baseline and evaluation framing used by later work.\n  - [Similar Paper] Learning single-cell perturbation responses using neural optimal transport (CellOT)\n    Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein.\n  - [Patent] US20240386990A1: Predicting cellular responses to perturbations\n    Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims.\n\nSummary: Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.\n\nClaim: C3\nOriginal: A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation.\n  - [Research Group] Google Research blog on C2S-Scale interferon-conditional amplifier\n    Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model.\n  - [Patent] WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes\n    Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase.\n  - [Patent] WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders\n    Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation.\n  - [Patent] US10227344B2: CK2 inhibitors, compositions and methods thereof\n    Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation.\n\nSummary: Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                  "relevance": "Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation."
                },
                {
                  "source": "Similar Paper",
                  "title": "A single-cell gene expression language model (Exceiver)",
                  "relevance": "Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent."
                },
                {
                  "source": "Research Group",
                  "title": "Cell2Sentence GitHub repository",
                  "relevance": "Implementation and resources released, enabling some level of reproducibility."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale."
                }
              ],
              "verificationSummary": "The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component."
                },
                {
                  "source": "Similar Paper",
                  "title": "scGen predicts single-cell perturbation responses",
                  "relevance": "Provides a canonical perturbation-prediction baseline and evaluation framing used by later work."
                },
                {
                  "source": "Similar Paper",
                  "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
                  "relevance": "Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein."
                },
                {
                  "source": "Patent",
                  "title": "US20240386990A1: Predicting cellular responses to perturbations",
                  "relevance": "Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims."
                }
              ],
              "verificationSummary": "Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation."
                },
                {
                  "source": "Research Group",
                  "title": "Google Research blog on C2S-Scale interferon-conditional amplifier",
                  "relevance": "Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model."
                },
                {
                  "source": "Patent",
                  "title": "WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes",
                  "relevance": "Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase."
                },
                {
                  "source": "Patent",
                  "title": "WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders",
                  "relevance": "Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation."
                },
                {
                  "source": "Patent",
                  "title": "US10227344B2: CK2 inhibitors, compositions and methods thereof",
                  "relevance": "Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "Across claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.",
          "promptNotes": "Most supporting results originate from the authors' own preprint and communications; independent replications are not yet available. The scFID metric is new and not widely benchmarked. Blog posts and press releases are not peer-reviewed sources and were treated as Research Group communications."
        }
      }
    },
    {
      "id": "hartmann-six-2023",
      "sourcePdf": {
        "path": "Hartmann & Six (2023).pdf",
        "publicPath": "/mock-papers/hartmann-six-2023.pdf",
        "title": "Soil structure and microbiome functions in agroecosystems",
        "originalFileName": "Hartmann & Six (2023).pdf",
        "doi": "10.1038/s43017-022-00366-w",
        "pages": 15
      },
      "label": "Hartmann & Six (2023)",
      "generatedAt": "2025-10-28T03:13:16.766Z",
      "claimsAnalysis": {
        "text": "Executive Summary   This review argues that soil structure governs microbiome function in agroecosystems and that management practices that protect or rebuild structure enhance beneficial microbial processes. Headline numbers include: approximately half of the ~120 Pg C emitted annually on land arises from heterotrophic microbial respiration; methanogens produce about two-thirds of the 500-600 Tg CH4 per year while methanotrophs consume roughly 60% of global CH4 and oxidise ~30 Tg directly from the atmosphere; soils emit ~6.8 Tg N2O per year (~65% of global total), with agriculture responsible for ~52% of anthropogenic N2O. A case example shows a 53% tomato yield increase with N2O reduced from ~2.01 to 0.58 kg N2O-N ha -1 under an integrated system. Overall evidence strength: Moderate (broad, well-established mechanisms and multiple quantitative figures, but this is a narrative review with context-dependent outcomes and limited causal quantification across scales). (Abstract; pp. 5-6 Key functions; Fig. 1 p. 6-7; pp. 11-14 Management; \"Recommendations\" p. 14; integrated tomato system p. 14)  Top 3 Claims and Evidence  C1. One-sentence claim   Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes. (Abstract; \"Soil structure drives the microbiome\" pp. 8-10; Figs. 2-3 pp. 9-11)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field and experimental studies summarised with mechanistic figures. Measures include particle size fractions, aggregate habitats, pore size classes, organism distributions, and functional implications (carbon stabilisation, nitrification/denitrification, CH4/N2O flux). (pp. 8-10; Fig. 2)  Key numbers (effect size, CI, p, N, timeframe)   • 47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity. (p. 9)   • ~90% of soil bacteria associate with microaggregates, ~70% residing inside microaggregates; <10% on macroaggregate surfaces. (p. 9)   • Pore hierarchy: macropores >75 µm; pores between macroaggregates; within macroaggregates; within microaggregates; sharp O2 and nutrient gradients select for aerobic vs anaerobic guilds. (p. 10; Fig. 2)   • Microaggregate pores are likely simultaneous hotspots for C stabilisation and N2O emissions; the trade-off is not well understood or quantified. (p. 10)  Source location (page/section/figure/table)   \"Soil structure drives the microbiome\" (pp. 8-10); Fig. 2 (pp. 9-10); discussion of pore-scale trade-offs (p. 10).  Strength rating and assumptions   Strength: Moderate. Assumptions: \"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; consistent text elsewhere indicates >250 µm and <250 µm, so µm assumed. (p. 9; Fig. 2)  C2. One-sentence claim   Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets. (Abstract; \"Key functions of the soil microbiome\" pp. 5-7; Fig. 1 p. 6-7)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis collating global flux estimates and microbial pathway attributions (CO2 respiration, CH4 methanogenesis/methanotrophy, N2O from nitrification/denitrification). (pp. 5-6; Fig. 1)  Key numbers (effect size, CI, p, N, timeframe)   • ~50% of ~120 Pg C emitted per year on land is from heterotrophic microbial respiration; \"up to nine times more\" than yearly global anthropogenic sources. (p. 5)   • Methanogens are responsible for ~two-thirds of 500-600 Tg CH4 per year; methanotrophs oxidise ~30 Tg directly from the atmosphere and consume roughly 60% of globally produced CH4. (p. 5-6; Fig. 1)   • Soils contribute ~6.8 Tg N2O per year (~65% of global emissions); agriculture accounts for ~52% of global anthropogenic N2O. (p. 5-6)  Source location (page/section/figure/table)   \"Key functions of the soil microbiome - Climate regulation\" (pp. 5-6); Fig. 1 (p. 6-7).  Strength rating and assumptions   Strength: High for the general claim (well-established budgets and pathways as presented).  C3. One-sentence claim   Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent. (Abstract; \"Microbiome functions in agroecosystems\" pp. 11-14; Figs. 3-4 pp. 10-12)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field findings and meta-analytic patterns: effects of tillage on aggregation/fluxes, compaction on pore networks and GHGs, cover crops and rotations on microbial diversity and function, organic vs mineral fertilisers on structure and biogeochemistry; specific field case studies provided. (pp. 11-14; Figs. 3-4)  Key numbers (effect size, CI, p, N, timeframe)   • Compaction affects an estimated 68 million ha (~one-quarter of global agricultural land). (p. 12)   • Tillage increases CO2 emissions via macroaggregate breakdown; cessation of tillage can initially increase N2O but decreases with long-term no-tillage; CH4 generally decreases under conservation tillage due to a more stable pore network aiding methanotrophy. (pp. 12-13)   • Integrated tomato system (California): reduced tillage + drip fertigation + triticale cover crop increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha. (p. 14)   • Quesungual slash-and-mulch agroforestry system: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB), available P tripled, soil carbon increased; macrofauna biomass increased vs secondary forest (dry season 24.8 vs 4.3 g m-2; wet season 41.9 vs 13.1 g m-2). (p. 14)  Source location (page/section/figure/table)   \"Soil management,\" \"Crop management,\" \"External inputs,\" and \"Recommendations\" (pp. 11-14); Figs. 3-4 (pp. 10-12).  Strength rating and assumptions   Strength: Moderate. Effects are repeatedly noted as crop/soil/climate dependent; specific quantified case studies support plausibility but generalisability is limited.  Gaps & Limitations (linked to C1-C3)   • C1: Pore-scale trade-off between C stabilisation and N2O is \"not well understood, let alone quantified\"; aggregate dynamics under different interventions are \"rarely directly investigated.\" (p. 10)   • C2: The review provides budgets and attributions but no new primary quantification; pathway contributions can vary by soil and management, which is not resolved here. (pp. 5-6)   • C3: Outcomes are context-dependent and sometimes contradictory (e.g., N2O under no-till; variable biochar and organic fertiliser effects; inoculant establishment and non-target effects uncertain). Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes remain sparse. (pp. 12-14)  Methods Snapshot   Narrative review using an online network-based literature mapping tool (Research Rabbit) to identify relevant literature; synthesised mechanisms and management impacts with integrative figures and selected quantitative examples. No formal systematic review protocol or meta-analysis is described. (Introduction, p. 5)  Risk-of-Bias/Quality Checklist   • Literature identification: non-systematic mapping; potential selection bias. (p. 5)   • Heterogeneity: acknowledged context dependence across soils, climates, crops. (pp. 12-14)   • Causality: many inferences are mechanistic or associative; limited direct multiscale causal quantification. (pp. 9-10, 12-14)   • Precision/reporting: many figures are qualitative; where numbers are given they are reported here exactly as in the text.   • External validity: strong conceptual generality; site-specific performance and trade-offs remain to be validated broadly. (pp. 12-15)  Open Questions & Next Steps   • Quantify the pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels. (p. 10)   • Link microscale physicochemical gradients (within/among aggregates) to cell-level activity using imaging and tracing (e.g., NanoSIMS, Raman) combined with single-cell genomics. (p. 15)   • Run long-term, cross-soil/climate trials that connect management (no-till, cover crops, organic inputs, IPM/ISFM) to aggregate/pore architecture and specific microbial guild functions, including GHG outcomes. (pp. 12-15)   • Resolve when and where microbial inoculants reliably persist and benefit structure/function vs when promoting native communities is preferable; assess legacy and non-target effects. (pp. 13-14)   • Expand research in developing countries and underrepresented soil types where reliance on nature-based solutions is high. (p. 15)  QA checks   • All required sections present.   • Numbers reproduced verbatim.   • Each claim includes strength and source locations.   • OCR artefact flagged: \"Macroaggregate >250 mm\" in Fig. 2 interpreted as >250 µm based on surrounding text. (p. 9; Fig. 2)",
        "structured": {
          "executiveSummary": [
            "Soil structure governs microbiome function in agroecosystems; protecting or rebuilding structure enhances beneficial microbial processes.",
            "Headline numbers: ~50% of ~120 Pg C land emissions from heterotrophic microbial respiration; methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs consume ~60% of global CH4 and oxidise ~30 Tg from atmosphere; soils emit ~6.8 Tg N2O yr-1 (~65% of global), agriculture ~52% of anthropogenic N2O.",
            "Case example: integrated tomato system increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha -1.",
            "Overall evidence strength: Moderate (narrative review; context-dependent outcomes; limited causal quantification across scales)."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "evidenceSummary": "Narrative synthesis of field and experimental studies with mechanistic figures; measures include particle size fractions, aggregate habitats, pore classes, organism distributions, and functional implications (C stabilisation, nitrification/denitrification, CH4/N2O flux).",
              "keyNumbers": [
                "47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity.",
                "~90% of soil bacteria associate with microaggregates; ~70% inside microaggregates; <10% on macroaggregate surfaces.",
                "Macropores >75 µm; hierarchical pore network; sharp O2 and nutrient gradients selecting aerobic vs anaerobic guilds.",
                "Microaggregate pores likely hotspots for C stabilisation and N2O emissions; trade-off not quantified."
              ],
              "source": "\"Soil structure drives the microbiome\" pp. 8-10; Fig. 2 pp. 9-10; pore-scale trade-offs p. 10.",
              "strength": "Moderate",
              "assumptions": "\"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; assumed µm based on surrounding text.",
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C2",
              "claim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "evidenceSummary": "Narrative synthesis compiling global flux estimates and microbial pathway attributions for CO2, CH4, and N2O.",
              "keyNumbers": [
                "~50% of ~120 Pg C emitted per year on land from heterotrophic microbial respiration; up to nine times more than yearly global anthropogenic sources.",
                "Methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs oxidise ~30 Tg directly from atmosphere and consume roughly 60% of global CH4.",
                "Soils ~6.8 Tg N2O yr-1 (~65% of global emissions); agriculture ~52% of global anthropogenic N2O."
              ],
              "source": "Key functions pp. 5-6; Fig. 1 pp. 6-7.",
              "strength": "High",
              "assumptions": null,
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C3",
              "claim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "evidenceSummary": "Narrative synthesis of field findings/meta-analytic patterns on tillage, compaction, cover crops, fertilisers, and case studies (integrated tomato system; QSMAS).",
              "keyNumbers": [
                "Compaction affects ~68 million ha (~one-quarter of global agricultural land).",
                "Under conservation tillage: CO2 increases with tillage; N2O may initially rise then fall with long-term no-till; CH4 generally decreases as stable pore networks aid methanotrophy.",
                "Integrated tomato system: yield ↑ ~53%; N2O reduced from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha.",
                "QSMAS: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB); available P tripled; macrofauna biomass vs secondary forest - dry 24.8 vs 4.3 g m-2; wet 41.9 vs 13.1 g m-2."
              ],
              "source": "Soil/Crop/External inputs pp. 11-14; Figs. 3-4 pp. 10-12; Recommendations p. 14.",
              "strength": "Moderate",
              "assumptions": "Effects are crop/soil/climate dependent; generalisability limited beyond reported contexts.",
              "evidenceType": "Narrative review with case studies"
            }
          ],
          "gaps": [
            {
              "category": "Quantification gap",
              "detail": "Pore-scale C-stabilisation vs N2O trade-off not well understood or quantified.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Evidence gap",
              "detail": "Aggregate dynamics under different interventions rarely investigated directly.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Generalisability",
              "detail": "Budgets and pathway attributions synthesised without new primary quantification; variability by soil/management unresolved.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Intervention heterogeneity",
              "detail": "Context-dependent and sometimes contradictory outcomes (e.g., N2O under no-till; variable biochar/organic fertiliser effects; inoculant establishment and non-target effects uncertain).",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Causal linkage",
              "detail": "Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes are sparse.",
              "relatedClaimIds": [
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Narrative review using Research Rabbit to identify literature.",
            "Synthesised mechanisms and management impacts with integrative figures and selected quantitative examples.",
            "No formal systematic review protocol or meta-analysis described."
          ],
          "riskChecklist": [
            {
              "item": "Literature identification approach",
              "status": "partial",
              "note": "Non-systematic mapping; potential selection bias."
            },
            {
              "item": "Heterogeneity acknowledged",
              "status": "met",
              "note": "Context dependence across soils, climates, crops explicitly noted."
            },
            {
              "item": "Causality support",
              "status": "partial",
              "note": "Mechanistic/associative inferences; limited direct multiscale causal quantification."
            },
            {
              "item": "Precision/reporting of effects",
              "status": "partial",
              "note": "Many qualitative figures; quantitative numbers provided selectively."
            },
            {
              "item": "External validity",
              "status": "partial",
              "note": "Strong conceptual generality; site-specific performance and trade-offs need broader validation."
            },
            {
              "item": "Registration/protocol",
              "status": "missing",
              "note": "No protocol or registration stated."
            },
            {
              "item": "Meta-analysis",
              "status": "missing",
              "note": "No formal meta-analysis reported."
            }
          ],
          "openQuestions": [
            "Quantify pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels.",
            "Link microscale gradients to single-cell activity using imaging/tracing with single-cell genomics.",
            "Long-term cross-soil/climate trials connecting management to aggregate/pore architecture and specific microbial guild functions including GHG outcomes.",
            "Establishment, persistence, benefits, and risks of microbial inoculants vs promoting native communities; assess legacy and non-target effects.",
            "Expand research in developing countries and underrepresented soil types with high reliance on nature-based solutions."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T06:01:46.288Z",
      "updatedAt": "2025-10-28T04:15:33.620Z",
      "agent": {
        "maxChars": 9188,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Soil structure and microbiome functions in agroecosystems",
        "summary": "Narrative review arguing that soil structure governs microbiome function and that conservation management that protects or rebuilds structure enhances beneficial processes, with headline greenhouse gas budgets and selected case studies.",
        "keyMethodSignals": [
          "Particle size fractionation and aggregate class comparisons",
          "Pore size classes and connectivity linked to guild distributions",
          "Mechanistic synthesis of carbon stabilisation, nitrification and denitrification",
          "Compilation of global CO2, CH4 and N2O flux attributions",
          "Management comparisons on tillage, compaction, cover crops and fertilisers"
        ],
        "methodComparison": {
          "sample": "Field and laboratory soils across multiple climates, crops and management regimes summarised from the literature.",
          "materials": "Measures emphasised particle size fractions, aggregate habitats, pore network classes and microbial guild distributions relevant to greenhouse gas pathways.",
          "equipment": "Typical wet sieving and fractionation setups, imaging and gas flux methods referenced across studies rather than a single instrument set.",
          "procedure": "Non systematic literature mapping and integrative synthesis with mechanistic figures and selected quantitative examples including global flux numbers.",
          "outcomes": "Conceptual linkage from soil structure to microenvironments to guild activity and greenhouse gas outcomes, with context dependent management effects."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.3389/fmicb.2018.00149",
          "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
          "authors": [
            "Hemkemeyer M",
            "et al."
          ],
          "year": 2018,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Direct match to particle and aggregate fractionation with gentle dispersion and microhabitat specific DNA analyses. Strong overlap with structure driven assembly central to the brief.",
          "methodOverlap": [
            "Gentle ultrasonication and wet sieving into sand silt clay fractions",
            "qPCR quantification of 16S and domain markers per fraction",
            "Amplicon sequencing maps taxa across particle size fractions"
          ],
          "methodComparison": {
            "sample": "Long term experimental plots at Askov, Denmark, 0 to 18 cm, multiple fertiliser histories pooled before fractionation.",
            "materials": "Particle size fractionation protocol with mild dispersants and MgCl2, DNA extraction kits, 16S primers for bacteria and archaea.",
            "equipment": "Probe sonicator, sieves at 63 and 20 micrometres, centrifuges, StepOnePlus qPCR platform, Illumina MiSeq.",
            "procedure": "Minimal energy dispersion, sequential separation of fractions, DNA extraction from each fraction, qPCR and dual indexed 16S sequencing.",
            "outcomes": "Clear taxon sorting among fractions with fine silt and clay enriched for diversity and microbial load."
          },
          "gaps": "No direct greenhouse gas flux measurements. Storage and handling may bias community composition. Functional conclusions rely on gene and amplicon data rather than process rates.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fevo.2022.1091773",
          "title": "Micro fractionation Shows Microbial Community Changes in Soil Particles Below 20 micrometres",
          "authors": [
            "Keuschnig M",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Ecology and Evolution",
          "whyRelevant": "Sub 20 micrometre focus with size verified fractions and per fraction DNA plus nitrogen cycle marker genes. Aligns with aggregate and pore scale niche mechanisms in the brief.",
          "methodOverlap": [
            "Fractionation preserving microaggregates including less than 2 micrometres fractions",
            "Laser granulometry verifies fraction sizes and stability",
            "Denitrifier marker genes enriched in larger aggregates"
          ],
          "methodComparison": {
            "sample": "Park Grass soil, 0 to 21 cm, unmanaged reference site, micro fractionation preserving small aggregates and supernatant.",
            "materials": "Fractionation hardware, Mastersizer type laser granulometer, DNA kits, primer sets for nirK, nirS and nosZ.",
            "equipment": "Laser granulometer, centrifuges, thermal cycler and qPCR system, sequencing platform.",
            "procedure": "Fractionate soil, verify sizes by laser granulometry, extract DNA from each fraction, quantify community composition and nitrogen cycle markers.",
            "outcomes": "Distinct community shifts at and below 20 micrometres and higher denitrifier gene abundance in larger aggregates."
          },
          "gaps": "Relies on gene proxies rather than in situ process rates. No direct N2O flux measurements. Single site and unmanaged soil limit transferability to managed agroecosystems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fmicb.2022.831746",
          "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
          "authors": [
            "Rui J",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Aggregate resolved wet sieving with per fraction DNA and network analyses under long term fertilisation. Mirrors the briefs aggregate microhabitat framing and adds a management lever.",
          "methodOverlap": [
            "Water stable aggregate fractionation across five size classes",
            "qPCR and amplicon sequencing applied to each aggregate fraction",
            "Macroaggregates identified as enriched functional micro hotspots"
          ],
          "methodComparison": {
            "sample": "Paddy topsoil from a long term fertiliser experiment initiated in 1987 with replicated treatments.",
            "materials": "Nylon sieves for wet sieving, centrifugation for fine fractions, PowerSoil type DNA kits, ITS and 16S primers.",
            "equipment": "Wet sieving setup, centrifuges, quantitative PCR system, sequencing instruments.",
            "procedure": "Fractionate water stable aggregates, characterise physicochemical properties and microbial abundance and diversity, infer co occurrence networks and functional potential.",
            "outcomes": "Macroaggregates showed higher microbial abundance and network connectivity, and fertilisation altered diversity and composition."
          },
          "gaps": "No direct greenhouse gas flux or process rate measurements. Paddy specific conditions and potential confounders reduce generalisability to upland systems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1371/journal.pone.0187681",
          "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
          "authors": [
            "Zurovec O",
            "et al."
          ],
          "year": 2017,
          "venue": "PLOS ONE",
          "whyRelevant": "Field comparison of conventional, reduced and no tillage with direct N2O flux monitoring and soil structural measurements. Matches the briefs emphasis on management trade offs and structure function links.",
          "methodOverlap": [
            "Weekly static chamber N2O fluxes under contrasting tillage systems",
            "Undisturbed core sampling for bulk density and porosity",
            "Yield scaled N2O and economic assessment of treatments"
          ],
          "methodComparison": {
            "sample": "Maize to barley rotation on a Fluvisol over two seasons with replicated treatment strips.",
            "materials": "Static chambers, stainless steel core cylinders, standard mineral fertilisers and crop management inputs.",
            "equipment": "Gas chromatography for N2O analysis, core sampling hardware, devices to determine bulk density and porosity.",
            "procedure": "Apply tillage treatments and standard nitrogen inputs, measure weekly N2O fluxes, collect end season soil physics, compute yield and cost metrics.",
            "outcomes": "Treatment ranking of N2O varied between wet and dry years, fertiliser pulses dominated emissions, reduced tillage had lowest yield scaled N2O in year one."
          },
          "gaps": "Short duration and single site limit inference strength. No aggregate resolved microbiology, so mechanisms are inferred via water filled pore space and structure metrics.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41598-019-47861-7",
          "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
          "authors": [
            "Ogle S",
            "et al."
          ],
          "year": 2019,
          "venue": "Scientific Reports",
          "whyRelevant": "Global dataset and semi parametric mixed effects modelling of tillage impacts on soil carbon with explicit treatment of depth and uncertainty. Mirrors the briefs synthesis style for management effects relevant to greenhouse gas outcomes.",
          "methodOverlap": [
            "Literature based compilation with explicit inclusion criteria",
            "Depth explicit modelling of soil carbon change with climate and texture",
            "Addresses sampling depth and mass equivalency in analysis"
          ],
          "methodComparison": {
            "sample": "Controlled experiments worldwide comparing conventional and no till with 178 sites and more than one thousand observations.",
            "materials": "Extracted data on soil organic carbon, bulk density, texture and climate metadata from primary studies.",
            "equipment": "Statistical computing environment for mixed effects models and uncertainty analysis.",
            "procedure": "Apply inclusion criteria, extract variables, fit semi parametric mixed effects models with depth and time covariates and evaluate uncertainty.",
            "outcomes": "No till increases carbon near the surface while conventional till often stores more deeper, with climate and texture governing sign and magnitude."
          },
          "gaps": "Focuses on soil carbon rather than partitioned greenhouse gas fluxes. Observational heterogeneity remains and deep soil layers are under sampled.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "researchGroups": {
        "maxChars": 7996,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)\nGroup: Microbiome Research (ETH Zürich; affiliated with Agroscope)\nWebsite: https://microbiome.ch\nSummary: Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)\n| Name | Email | Role |\n| --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nGroup: Sustainable Agroecosystems (ETH Zürich)\nWebsite: https://sae.ethz.ch\nSummary: Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.\n| Name | Email | Role |\n| --- | --- | --- |\n| Johan Six | jsix@ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nPaper: Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019) (10.1038/s41467-019-11057-4)\nGroup: Soil and Environmental Physics (Swedish University of Agricultural Sciences, SLU)\nWebsite: https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/\nSummary: Koestel's team uses X-ray µCT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.\n| Name | Email | Role |\n| --- | --- | --- |\n| John Koestel | john.koestel@slu.se | Associate Professor (PI) |\n| Nick Jarvis | nicholas.jarvis@slu.se | Professor, group contact |\n| Soil Physics Lab | soilphysicslab@slu.se | Laboratory contact (samples, µCT logistics) |\n\nGroup: W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems (Michigan State University)\nWebsite: https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/\nSummary: Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.\n| Name | Email | Role |\n| --- | --- | --- |\n| G. Philip Robertson | robert30@msu.edu | PI |\n| KBS Directory | check lab website contact form | Use \"People\" directory for current postdocs and PhD students |\n\nPaper: Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017) (10.1038/s41467-017-01406-6)\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford Doerr School of Sustainability)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Team contacts | use stanford profiles for current postdocs and phd students | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (current) |\n| Emily M. Lacroix | emily.lacroix@unil.ch | Postdoctoral Researcher (redox/anoxic microsites) |\n\nPaper: Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014) (10.2134/jeq2014.03.0125)\nGroup: Danish Center for Hadal Research & NordCEE (Glud group) (University of Southern Denmark)\nWebsite: https://www.sdu.dk/en/forskning/hadal/people\nSummary: Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.\n| Name | Email | Role |\n| --- | --- | --- |\n| Ronnie N. Glud | rnglud@biology.sdu.dk | Professor, Center Director |\n| Wenjie Xiao | wjxiao@biology.sdu.dk | Postdoctoral Researcher |\n| Blandine Trouche | blandinetrouche@biology.sdu.dk | Postdoctoral Researcher |\n\nGroup: Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science (University of Copenhagen)\nWebsite: https://plen.ku.dk/english/research/plant_soil/\nSummary: Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.\n| Name | Email | Role |\n| --- | --- | --- |\n| Lars Stoumann Jensen | lsj@plen.ku.dk | Professor, Soil Fertility |\n| Sander Bruun | sab@plen.ku.dk | Professor, Climate Change & Soil Management |\n| Xiaoxiao Qin | xq@plen.ku.dk | PhD Fellow (Plant and Soil Science) |\n\nPaper: Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013) (10.1111/j.1365-2486.2012.02779.x)\nGroup: Rice Systems & GHG Mitigation (Linquist Lab) (UC Davis)\nWebsite: https://linquist.ucdavis.edu/\nSummary: Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.\n| Name | Email | Role |\n| --- | --- | --- |\n| Bruce A. Linquist | balinquist@ucdavis.edu | PI |\n| Whitney Brim-DeForest | wbrimdeforest@ucanr.edu | Rice Advisor, collaborator |\n| Luis Espino | laespino@ucanr.edu | Rice Advisor, collaborator |\n\nGroup: Soil & Water Management Research Unit (Venterea group) (USDA-ARS, St Paul, MN)\nWebsite: https://www.ars.usda.gov/midwest-area/stpaul/swmr/\nSummary: Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.\n| Name | Email | Role |\n| --- | --- | --- |\n| Rodney T. Venterea | venterea@umn.edu | Research Soil Scientist (PI) |\n| Unit main office | check lab website contact form | Use unit site contact for current postdocs/GSRA contacts |\n\nPaper: Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024) (10.1021/acs.est.4c01882)\nGroup: Dekas Geomicrobiology Laboratory (Stanford University)\nWebsite: https://dekaslab.stanford.edu/\nSummary: Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.\n| Name | Email | Role |\n| --- | --- | --- |\n| Anne E. Dekas | dekas@stanford.edu | PI |\n| Current members | use lab “people” page for up-to-date student and postdoc roster | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Emily M. Lacroix | emily.lacroix@unil.ch | First author, Postdoctoral Researcher |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (methods on rhizosphere anoxia) |\n\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Collaborator list | see project and publication pages for current trainees on the proxy work | Check lab website contact form |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)",
              "identifier": null,
              "groups": [
                {
                  "name": "Microbiome Research",
                  "institution": "ETH Zürich; affiliated with Agroscope",
                  "website": "https://microbiome.ch",
                  "notes": "Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)",
                  "researchers": [
                    {
                      "name": "Martin Hartmann",
                      "email": "martin.hartmann@usys.ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                },
                {
                  "name": "Sustainable Agroecosystems",
                  "institution": "ETH Zürich",
                  "website": "https://sae.ethz.ch",
                  "notes": "Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.",
                  "researchers": [
                    {
                      "name": "Johan Six",
                      "email": "jsix@ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019)",
              "identifier": "10.1038/s41467-019-11057-4",
              "groups": [
                {
                  "name": "Soil and Environmental Physics",
                  "institution": "Swedish University of Agricultural Sciences, SLU",
                  "website": "https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/",
                  "notes": "Koestel's team uses X-ray µCT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.",
                  "researchers": [
                    {
                      "name": "John Koestel",
                      "email": "john.koestel@slu.se",
                      "role": "Associate Professor (PI)"
                    },
                    {
                      "name": "Nick Jarvis",
                      "email": "nicholas.jarvis@slu.se",
                      "role": "Professor, group contact"
                    },
                    {
                      "name": "Soil Physics Lab",
                      "email": "soilphysicslab@slu.se",
                      "role": "Laboratory contact (samples, µCT logistics)"
                    }
                  ]
                },
                {
                  "name": "W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems",
                  "institution": "Michigan State University",
                  "website": "https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/",
                  "notes": "Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.",
                  "researchers": [
                    {
                      "name": "G. Philip Robertson",
                      "email": "robert30@msu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "KBS Directory",
                      "email": "check lab website contact form",
                      "role": "Use \"People\" directory for current postdocs and PhD students"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017)",
              "identifier": "10.1038/s41467-017-01406-6",
              "groups": [
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford Doerr School of Sustainability",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Team contacts",
                      "email": "use stanford profiles for current postdocs and phd students",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (current)"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "Postdoctoral Researcher (redox/anoxic microsites)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014)",
              "identifier": "10.2134/jeq2014.03.0125",
              "groups": [
                {
                  "name": "Danish Center for Hadal Research & NordCEE (Glud group)",
                  "institution": "University of Southern Denmark",
                  "website": "https://www.sdu.dk/en/forskning/hadal/people",
                  "notes": "Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.",
                  "researchers": [
                    {
                      "name": "Ronnie N. Glud",
                      "email": "rnglud@biology.sdu.dk",
                      "role": "Professor, Center Director"
                    },
                    {
                      "name": "Wenjie Xiao",
                      "email": "wjxiao@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    },
                    {
                      "name": "Blandine Trouche",
                      "email": "blandinetrouche@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    }
                  ]
                },
                {
                  "name": "Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science",
                  "institution": "University of Copenhagen",
                  "website": "https://plen.ku.dk/english/research/plant_soil/",
                  "notes": "Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.",
                  "researchers": [
                    {
                      "name": "Lars Stoumann Jensen",
                      "email": "lsj@plen.ku.dk",
                      "role": "Professor, Soil Fertility"
                    },
                    {
                      "name": "Sander Bruun",
                      "email": "sab@plen.ku.dk",
                      "role": "Professor, Climate Change & Soil Management"
                    },
                    {
                      "name": "Xiaoxiao Qin",
                      "email": "xq@plen.ku.dk",
                      "role": "PhD Fellow (Plant and Soil Science)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013)",
              "identifier": "10.1111/j.1365-2486.2012.02779.x",
              "groups": [
                {
                  "name": "Rice Systems & GHG Mitigation (Linquist Lab)",
                  "institution": "UC Davis",
                  "website": "https://linquist.ucdavis.edu/",
                  "notes": "Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.",
                  "researchers": [
                    {
                      "name": "Bruce A. Linquist",
                      "email": "balinquist@ucdavis.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Whitney Brim-DeForest",
                      "email": "wbrimdeforest@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    },
                    {
                      "name": "Luis Espino",
                      "email": "laespino@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    }
                  ]
                },
                {
                  "name": "Soil & Water Management Research Unit (Venterea group)",
                  "institution": "USDA-ARS, St Paul, MN",
                  "website": "https://www.ars.usda.gov/midwest-area/stpaul/swmr/",
                  "notes": "Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.",
                  "researchers": [
                    {
                      "name": "Rodney T. Venterea",
                      "email": "venterea@umn.edu",
                      "role": "Research Soil Scientist (PI)"
                    },
                    {
                      "name": "Unit main office",
                      "email": "check lab website contact form",
                      "role": "Use unit site contact for current postdocs/GSRA contacts"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024)",
              "identifier": "10.1021/acs.est.4c01882",
              "groups": [
                {
                  "name": "Dekas Geomicrobiology Laboratory",
                  "institution": "Stanford University",
                  "website": "https://dekaslab.stanford.edu/",
                  "notes": "Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.",
                  "researchers": [
                    {
                      "name": "Anne E. Dekas",
                      "email": "dekas@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Current members",
                      "email": "use lab “people” page for up-to-date student and postdoc roster",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "First author, Postdoctoral Researcher"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (methods on rhizosphere anoxia)"
                    }
                  ]
                },
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Collaborator list",
                      "email": "see project and publication pages for current trainees on the proxy work",
                      "role": "Check lab website contact form"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 5917,
        "truncated": false,
        "text": "Researcher: Martin Hartmann\nEmail: [martin.hartmann@usys.ethz.ch](mailto:martin.hartmann@usys.ethz.ch)\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops\n  - Year: 2006\n  - Institution: ETH Zürich\n  - URL: https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download\n\nResearcher: Johan Six\nEmail: [johan.six@usys.ethz.ch](mailto:johan.six@usys.ethz.ch)\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems\n  - Year: 1998\n  - Institution: Colorado State University\n  - URL: Not found\n\nResearcher: Michael Hemkemeyer\nEmail: [hemkemeyer@uni-wuppertal.de](mailto:hemkemeyer@uni-wuppertal.de)\nData publicly available: unknown\nLatest publication:\n  - Title: Potato yield and quality are linked to cover crop species and soil microorganisms\n  - Year: 2024\n  - Venue: Biology and Fertility of Soils\n  - URL: https://link.springer.com/article/10.1007/s00374-024-01810-3\nPhD thesis:\n  - Title: Importance of soil primary particles for shaping the diversity and activity of soil microbial communities\n  - Year: 2021\n  - Institution: Technische Universität Braunschweig\n  - URL: Not found\n\nResearcher: Christoph C. Tebbe\nEmail: [christoph.tebbe@thuenen.de](mailto:christoph.tebbe@thuenen.de)\nData publicly available: unknown\nLatest publication:\n  - Title: Status and trends in soil biodiversity - a national survey of Germany\n  - Year: 2025\n  - Venue: Soil Organisms\n  - URL: https://soil-organisms.org/index.php/SO/article/view/449\nPhD thesis: Not found\n\nResearcher: Christoph Keuschnig\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics\n  - Year: 2024\n  - Venue: BMC Microbiology\n  - URL: https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1\nPhD thesis:\n  - Title: Implication des champignons et des bactéries dans le cycle de l'azote et la production de N2O dans le sol\n  - Year: 2016\n  - Institution: École Centrale de Lyon, Université de Lyon\n  - URL: https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf\n\nResearcher: Catherine Larose\nEmail: [catherine.larose@ec-lyon.fr](mailto:catherine.larose@ec-lyon.fr)\nData publicly available: unknown\nLatest publication:\n  - Title: Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dôme summit (Central France)\n  - Year: 2024\n  - Venue: Science of the Total Environment\n  - URL: https://doi.org/10.1016/j.scitotenv.2023.169567\nPhD thesis:\n  - Title: Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les conséquences sur le cycle du mercure en Arctique\n  - Year: 2010\n  - Institution: Université Joseph Fourier - Grenoble 1\n  - URL: https://core.ac.uk/download/pdf/52739764.pdf\n\nResearcher: Ognjen Žurovec\nEmail: [ognjen.zurovec@nmbu.no](mailto:ognjen.zurovec@nmbu.no)\nData publicly available: unknown\nLatest publication:\n  - Title: Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme\n  - Year: 2022\n  - Venue: Irish Journal of Agricultural and Food Research\n  - URL: https://doi.org/10.15212/ijafr-2020-0145\nPhD thesis:\n  - Title: Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation\n  - Year: 2018\n  - Institution: Norwegian University of Life Sciences (NMBU)\n  - URL: https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198\n\nResearcher: Peter Dörsch\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations\n  - Year: 2024\n  - Venue: Biogeosciences\n  - URL: https://bg.copernicus.org/articles/21/4723/2024/\nPhD thesis:\n  - Title: Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany\n  - Year: 1999\n  - Institution: Technische Universität München\n  - URL: https://www.finna.fi/Record/vaari.926379\n\nResearcher: Stephen M. Ogle\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States\n  - Year: 2023\n  - Venue: Scientific Reports\n  - URL: https://www.nature.com/articles/s41598-023-41307-x\nPhD thesis:\n  - Title: Not found\n  - Year: 2000\n  - Institution: University of Wyoming\n  - URL: Not found\n\nResearcher: Gabriel G. Vázquez-Amabile\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems\n  - Year: 2025\n  - Venue: Soil & Tillage Research\n  - URL: https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X\nPhD thesis:\n  - Title: Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds\n  - Year: 2005\n  - Institution: Purdue University\n  - URL: https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL",
        "structured": {
          "researchers": [
            {
              "name": "Martin Hartmann",
              "email": "[martin.hartmann@usys.ethz.ch](mailto:martin.hartmann@usys.ethz.ch)",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops",
                "year": 2006,
                "institution": "ETH Zürich",
                "url": "https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Johan Six",
              "email": "[johan.six@usys.ethz.ch](mailto:johan.six@usys.ethz.ch)",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems",
                "year": 1998,
                "institution": "Colorado State University",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Michael Hemkemeyer",
              "email": "[hemkemeyer@uni-wuppertal.de](mailto:hemkemeyer@uni-wuppertal.de)",
              "latest_publication": {
                "title": "Potato yield and quality are linked to cover crop species and soil microorganisms",
                "year": 2024,
                "venue": "Biology and Fertility of Soils",
                "url": "https://link.springer.com/article/10.1007/s00374-024-01810-3"
              },
              "phd_thesis": {
                "title": "Importance of soil primary particles for shaping the diversity and activity of soil microbial communities",
                "year": 2021,
                "institution": "Technische Universität Braunschweig",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph C. Tebbe",
              "email": "[christoph.tebbe@thuenen.de](mailto:christoph.tebbe@thuenen.de)",
              "latest_publication": {
                "title": "Status and trends in soil biodiversity - a national survey of Germany",
                "year": 2025,
                "venue": "Soil Organisms",
                "url": "https://soil-organisms.org/index.php/SO/article/view/449"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph Keuschnig",
              "email": null,
              "latest_publication": {
                "title": "Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics",
                "year": 2024,
                "venue": "BMC Microbiology",
                "url": "https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1"
              },
              "phd_thesis": {
                "title": "Implication des champignons et des bactéries dans le cycle de l'azote et la production de N2O dans le sol",
                "year": 2016,
                "institution": "École Centrale de Lyon, Université de Lyon",
                "url": "https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Catherine Larose",
              "email": "[catherine.larose@ec-lyon.fr](mailto:catherine.larose@ec-lyon.fr)",
              "latest_publication": {
                "title": "Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dôme summit (Central France)",
                "year": 2024,
                "venue": "Science of the Total Environment",
                "url": "https://doi.org/10.1016/j.scitotenv.2023.169567"
              },
              "phd_thesis": {
                "title": "Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les conséquences sur le cycle du mercure en Arctique",
                "year": 2010,
                "institution": "Université Joseph Fourier - Grenoble 1",
                "url": "https://core.ac.uk/download/pdf/52739764.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Ognjen Žurovec",
              "email": "[ognjen.zurovec@nmbu.no](mailto:ognjen.zurovec@nmbu.no)",
              "latest_publication": {
                "title": "Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme",
                "year": 2022,
                "venue": "Irish Journal of Agricultural and Food Research",
                "url": "https://doi.org/10.15212/ijafr-2020-0145"
              },
              "phd_thesis": {
                "title": "Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation",
                "year": 2018,
                "institution": "Norwegian University of Life Sciences (NMBU)",
                "url": "https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Peter Dörsch",
              "email": null,
              "latest_publication": {
                "title": "Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations",
                "year": 2024,
                "venue": "Biogeosciences",
                "url": "https://bg.copernicus.org/articles/21/4723/2024/"
              },
              "phd_thesis": {
                "title": "Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany",
                "year": 1999,
                "institution": "Technische Universität München",
                "url": "https://www.finna.fi/Record/vaari.926379"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Stephen M. Ogle",
              "email": null,
              "latest_publication": {
                "title": "Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States",
                "year": 2023,
                "venue": "Scientific Reports",
                "url": "https://www.nature.com/articles/s41598-023-41307-x"
              },
              "phd_thesis": {
                "title": null,
                "year": 2000,
                "institution": "University of Wyoming",
                "url": null
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gabriel G. Vázquez-Amabile",
              "email": null,
              "latest_publication": {
                "title": "An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems",
                "year": 2025,
                "venue": "Soil & Tillage Research",
                "url": "https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X"
              },
              "phd_thesis": {
                "title": "Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds",
                "year": 2005,
                "institution": "Purdue University",
                "url": "https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": ""
        }
      },
      "patents": {
        "text": "Patent: EP3105198B1\nTitle: Soil bacteria for inoculating stress soils\nAssignee: Biofil Mikrobiologiai Gentechnologiai és Biokémiai Kft\nFiling Date: 2015-02-10\nGrant Date: 2022-02-16\nAbstract: Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3.\n\nPatent: WO2021030385A1\nTitle: Microbe-based compositions for restoring soil health and controlling pests\nAssignee: Locus Agriculture IP Co LLC\nFiling Date: 2020-08-12\nGrant Date: Not provided\nAbstract: Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.\nOverlaps with paper claims: C1, C2, C3\nTechnical overlap: The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3).\n\nPatent: WO2021076458A9\nTitle: Inhibitors of soil nitrification and processes to prevent same\nAssignee: Tessenderlo Group NV\nFiling Date: 2020-10-12\nGrant Date: Not provided\nAbstract: Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.\nOverlaps with paper claims: C2, C3\nTechnical overlap: Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3).\n\nPatent: WO2017117314A1\nTitle: Biochar as a microbial carrier\nAssignee: Cool Planet Energy Systems Inc\nFiling Date: 2016-12-28\nGrant Date: Not provided\nAbstract: Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3.\n\nPatent: WO2024100477A1\nTitle: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\nAssignee: Indian Council of Agricultural Research\nFiling Date: 2023-10-17\nGrant Date: Not provided\nAbstract: A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.\nOverlaps with paper claims: C2\nTechnical overlap: The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes.",
        "structured": {
          "patents": [
            {
              "patentNumber": "EP3105198B1",
              "title": "Soil bacteria for inoculating stress soils",
              "assignee": "Biofil Mikrobiologiai Gentechnologiai és Biokémiai Kft",
              "filingDate": "2015-02-10",
              "grantDate": "2022-02-16",
              "abstract": "Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021030385A1",
              "title": "Microbe-based compositions for restoring soil health and controlling pests",
              "assignee": "Locus Agriculture IP Co LLC",
              "filingDate": "2020-08-12",
              "grantDate": null,
              "abstract": "Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2",
                  "C3"
                ],
                "summary": "The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021076458A9",
              "title": "Inhibitors of soil nitrification and processes to prevent same",
              "assignee": "Tessenderlo Group NV",
              "filingDate": "2020-10-12",
              "grantDate": null,
              "abstract": "Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2",
                  "C3"
                ],
                "summary": "Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017117314A1",
              "title": "Biochar as a microbial carrier",
              "assignee": "Cool Planet Energy Systems Inc",
              "filingDate": "2016-12-28",
              "grantDate": null,
              "abstract": "Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2024100477A1",
              "title": "Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
              "assignee": "Indian Council of Agricultural Research",
              "filingDate": "2023-10-17",
              "grantDate": null,
              "abstract": "A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; dates normalised to ISO (YYYY-MM-DD). Grant dates set to null for applications without grant."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nThe paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n    Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure.\n  - [Similar Paper] Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil\n    Macroaggregates host functional microbial hotspots linking aggregate habitats to community function.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function.\n  - [Research Group] Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)\n    Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability.\n  - [Patent] EP3105198B1: Soil bacteria for inoculating stress soils\n    Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control.\n  - [Patent] WO2017117314A1: Biochar as a microbial carrier\n    Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity.\n\nSummary: Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.\n\nClaim: C2\nOriginal: Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Similar Paper] Global Nitrous Oxide Budget (2024)\n    Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification.\n  - [Similar Paper] Global Methane Budget (2024-2025)\n    Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics.\n  - [Patent] WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\n    Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes.\n  - [Patent] WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same\n    Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions.\n\nSummary: The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.\n\nClaim: C3\nOriginal: Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n    Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes.\n\nContradicting Evidence:\n  - [Similar Paper] Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)\n    Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers.\n  - [Similar Paper] Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n    Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management.\n\nSummary: Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
                  "relevance": "Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure."
                },
                {
                  "source": "Similar Paper",
                  "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
                  "relevance": "Macroaggregates host functional microbial hotspots linking aggregate habitats to community function."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function."
                },
                {
                  "source": "Research Group",
                  "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)",
                  "relevance": "Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability."
                },
                {
                  "source": "Patent",
                  "title": "EP3105198B1: Soil bacteria for inoculating stress soils",
                  "relevance": "Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control."
                },
                {
                  "source": "Patent",
                  "title": "WO2017117314A1: Biochar as a microbial carrier",
                  "relevance": "Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Global Nitrous Oxide Budget (2024)",
                  "relevance": "Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification."
                },
                {
                  "source": "Similar Paper",
                  "title": "Global Methane Budget (2024-2025)",
                  "relevance": "Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics."
                },
                {
                  "source": "Patent",
                  "title": "WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
                  "relevance": "Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes."
                },
                {
                  "source": "Patent",
                  "title": "WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same",
                  "relevance": "Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.",
              "confidenceLevel": "High"
            },
            {
              "claimId": "C3",
              "originalClaim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
                  "relevance": "Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)",
                  "relevance": "Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers."
                },
                {
                  "source": "Similar Paper",
                  "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
                  "relevance": "Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management."
                }
              ],
              "verificationSummary": "Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "The paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.",
          "promptNotes": "Independence: Evidence spans multiple groups and continents, plus unrelated patents.  Data availability: Global budgets are open; several studies have data supplements but analysis code is not always fully public.  Replication and rigour: Greenhouse gas findings are repeatedly synthesised; structure-function mechanisms are reproduced across methods, but effect sizes vary with context and some pipelines remain bespoke."
        }
      },
      "authorContacts": {
        "maxChars": 2349,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zürich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zürich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |\n\nPaper: Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Michael Hemkemeyer | hemkemeyer@uni-wuppertal.de | Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal | 0000-0002-2554-2231 |\n| Christoph C. Tebbe | christoph.tebbe@thuenen.de | Scientist, Thünen Institute of Biodiversity | 0000-0003-4861-0214 |\n\nPaper: Micro-fractionation shows microbial community changes in soil particles below 20 μm\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Christoph Keuschnig | Not found | MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam) | 0000-0002-5246-2640 |\n| Catherine Larose | catherine.larose@ec-lyon.fr | Environmental Microbial Genomics, École Centrale de Lyon, Université de Lyon | 0000-0001-5641-0701 |\n\nPaper: Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Ognjen Žurovec | ognjen.zurovec@nmbu.no | Department of International Environment and Development Studies, NMBU (Ås, Norway) | Not found |\n| Peter Dörsch | Not found | Faculty of Environmental Sciences and Natural Resource Management, NMBU | Not found |\n\nPaper: Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Stephen M. Ogle | Not found | Not found | Not found |\n| Gabriel G. Vázquez-Amabile | Not found | Not found | Not found |\n\nPaper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zürich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zürich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zürich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zürich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
              "identifier": null,
              "authors": [
                {
                  "name": "Michael Hemkemeyer",
                  "email": "hemkemeyer@uni-wuppertal.de",
                  "role": "Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal",
                  "orcid": "0000-0002-2554-2231",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=YNHGIpMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/hemkemeyer/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.boden.uni-wuppertal.de/en/home-1/dr-michael-hemkemeyer/"
                    }
                  ]
                },
                {
                  "name": "Christoph C. Tebbe",
                  "email": "christoph.tebbe@thuenen.de",
                  "role": "Scientist, Thünen Institute of Biodiversity",
                  "orcid": "0000-0003-4861-0214",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=a14fbqMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/christophtebbe/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.thuenen.de/en/institutes/biodiversity/staff/christoph-tebbe"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Micro-fractionation shows microbial community changes in soil particles below 20 μm",
              "identifier": null,
              "authors": [
                {
                  "name": "Christoph Keuschnig",
                  "email": null,
                  "role": "MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam)",
                  "orcid": "0000-0002-5246-2640",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://www.gfz.de/en/staff/christoph.keuschnig"
                    }
                  ]
                },
                {
                  "name": "Catherine Larose",
                  "email": "catherine.larose@ec-lyon.fr",
                  "role": "Environmental Microbial Genomics, École Centrale de Lyon, Université de Lyon",
                  "orcid": "0000-0001-5641-0701",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=NCuGHZgAAAAJ"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
              "identifier": null,
              "authors": [
                {
                  "name": "Ognjen Žurovec",
                  "email": "ognjen.zurovec@nmbu.no",
                  "role": "Department of International Environment and Development Studies, NMBU (Ås, Norway)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Peter Dörsch",
                  "email": null,
                  "role": "Faculty of Environmental Sciences and Natural Resource Management, NMBU",
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
              "identifier": null,
              "authors": [
                {
                  "name": "Stephen M. Ogle",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gabriel G. Vázquez-Amabile",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zürich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zürich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      }
    },
    {
      "id": "an-open-science-study-of-ageing-in-companion-dog",
      "sourcePdf": {
        "path": "An open science study of ageing in companion dogs.pdf",
        "publicPath": "/mock-papers/an-open-science-study-of-ageing-in-companion-dog.pdf",
        "title": "An open science study of ageing in companion dogs",
        "originalFileName": "An open science study of ageing in companion dogs.pdf",
        "doi": "10.1038/s41586-021-04282-9",
        "pages": 15
      },
      "label": "An open science study of ageing in companion dogs",
      "generatedAt": "2025-10-21T10:29:10.433Z",
      "claimsAnalysis": {
        "text": "# Executive Summary - The Dog Aging Project (DAP) is \"an open-data long-term longitudinal study of ageing in tens of thousands of companion dogs\" aiming to identify genetic, environmental and lifestyle determinants of healthy lifespan and to test interventions (Abstract; Creevy et al., p. 2). Overall evidence strength: **Moderate** for design and feasibility; **Low** for outcomes pending analyses. - DAP comprises observational cohorts plus TRIAD, a randomised, double-masked, placebo-controlled rapamycin trial in middle-aged large-breed dogs (Aims; p. 4; Key outcomes; p. 6; Table 1; Fig. 1a). - Data streams include owner surveys, veterinary electronic medical records, genomics for at least 10,000 dogs, multi-omics (metabolome, epigenome, microbiome), clinicopathology, accelerometry, and geocoded environmental data (Abstract; p. 4-5; Fig. 3; Table 1). - As of drafting, >30,000 canine participants enrolled; recruitment and retention supported by extensive community engagement (p. 2-3). - Open-science commitments include de-identified data on Terra and a biobank at Cornell; first public release planned for Q1/2022 (Data and sample release; p. 7; Fig. 3a). - Ethical oversight mirrors human-subjects frameworks and includes independent boards and an NIH-constituted monitoring board for TRIAD (Ethics; p. 6; p. 5). - Anticipated outcomes: canine-specific definitions of normative ageing, biomarkers, genetic architecture of age-related traits, and a test of rapamycin's geroprotective effects (Key outcomes; p. 6; Box 1). - Key limitations: results not yet reported; potential sampling biases; US-only geography; heavy reliance on owner-reported data and primary-care capture (p. 3-5; Fig. 1b).  # Key Claims and Evidence **C1.** *DAP will enable identification of genetic, environmental and lifestyle factors that influence ageing in dogs and facilitate translational insights to humans.* - **Evidence:** Prospective, multi-cohort longitudinal design with rich phenotyping and environmental linkage; open-data platform to support broad analyses. Quote: \"identify the genetic, environmental and lifestyle factors that influence ageing in dogs\" (Abstract; p. 2-5; Fig. 3; Table 1). - **Key numbers:** >30,000 dogs enrolled (p. 2). - **Source:** Abstract; p. 2-5; Fig. 3; Table 1. - **Strength:** **Moderate** for capability; outcomes pending.  **C2.** *Companion dogs are a suitable model for human ageing.* - **Evidence:** Dogs share human environments, experience similar age-related diseases within a sophisticated veterinary system, and age \"approximately seven to ten times faster than humans,\" enabling feasible longitudinal and interventional studies (p. 2). - **Key numbers:** Ageing rate 7-10× (p. 2). - **Source:** p. 2. - **Strength:** **Moderate**; conceptual rationale.  **C3.** *DAP's primary scientific aims span characterising ageing, large-scale genetics, multi-omics biomarkers, and an RCT of rapamycin (TRIAD).* - **Evidence:** Four aims explicitly listed (p. 4). TRIAD is randomised, double-masked, placebo-controlled, testing whether weekly low-dose rapamycin over one year increases lifespan and healthspan and improves cardiac and cognitive function (p. 4; p. 6; Table 1). - **Key numbers:** Low-coverage WGS with imputation for ≥10,000 dogs; Precision cohort n=1,000; TRIAD n=350. Enrolment into TRIAD began June 2021 and continues through 2022 (Fig. 3a; p. 6). - **Source:** p. 4; p. 6; Fig. 3a; Table 1. - **Strength:** **High** for design clarity; **Low** for efficacy conclusions pending results.  **C4.** *DAP has established scalable data collection, quality control, and participant engagement infrastructure.* - **Evidence:** REDCap-based portals; annual HLES and periodic targeted surveys; biospecimen QC with pre- and post-analytical data; reproducible computational pipelines; extensive owner communications. Quotes: \"document pre- and post-analytical quality data\" and \"created reproducible computational pipelines\" (p. 3-5). - **Key numbers:** Newsletter to >85,000; ~20,000 helpdesk enquiries resolved in 2020 (p. 3). - **Source:** p. 3-5. - **Strength:** **High** for operational feasibility.  **C5.** *DAP commits to open science via data and biospecimen access.* - **Evidence:** De-identified datasets on Terra with data use agreement; biobank managed at Cornell with access for qualified researchers and return-of-data conditions (p. 7; Fig. 3a). - **Key numbers:** First public release scheduled Q1/2022; Fig. 1 data available at data.dogagingproject.org (Data availability; p. 8). - **Source:** p. 7-8; Fig. 3a. - **Strength:** **High** for policy; **Low** for third-party reuse outcomes not yet shown.  **C6.** *Ethical oversight and informed consent mirror human research standards and include animal-specific safeguards.* - **Evidence:** Informed consent for owners; privacy policy; independent animal welfare and scientific advisory boards; NIH NIA data and safety monitoring board for TRIAD; engagement of veterinary and paediatric bioethicists (p. 3, 5-6). - **Key numbers:** Texas A&M IACUC approvals AUPs 2018-0401 CAM and 2018-0368 CAM (Acknowledgements; p. 8). - **Source:** p. 3; p. 5-6; p. 8. - **Strength:** **High** for governance.  # Gaps & Limitations - **Data gaps:** No primary outcomes or statistical results reported yet for genetics, biomarkers, or TRIAD efficacy (affects C1, C3). - **Sampling/selection:** Eligibility for sampled cohorts requires qualifying veterinary records, potentially biasing toward regularly cared-for dogs; one-dog-per-household policy; US-only enrolment (p. 3-4; Fig. 1b) (affects C1). - **Measurement error:** Heavy reliance on owner-reported data; age certainty is queried but still dependent on owner sources before veterinary confirmation (p. 4) (affects C1). - **External validity:** Translation to human ageing is argued but not empirically demonstrated within this paper (p. 2) (affects C2). - **Operational risks:** Multi-site biospecimen handling may introduce variability despite QC protocols (p. 5) (affects C1).  # Methods Snapshot - **Design:** Multi-cohort, longitudinal observational study plus an RCT (TRIAD) in companion dogs (Fig. 1a; p. 4). - **Sample:** >30,000 dogs across all US states; breeds mixed and pure; sizes, ages, sexes; sampled cohorts include Foundation, Precision (n=1,000), TRIAD (n=350), and a Centenarian cross-section (p. 2-4; Fig. 1; Fig. 3a). - **Measures:** Annual HLES; additional validated and bespoke surveys, morphometrics, cognitive tasks; veterinary EMRs; clinicopathology; low-pass WGS; epigenome, metabolome, microbiome; accelerometry; cardiology in TRIAD; geocoded environment datasets (p. 4-5; Table 1; Fig. 3b). - **Analysis approach:** Not fully specified; mentions imputation for low-pass WGS, systems-biology modelling of ageing, and development of prognostic and predictive biomarkers (p. 4; p. 6; Table 1). - **Ethics/oversight:** Informed consent, privacy policy, advisory boards, NIH monitoring board; Texas A&M IACUC approvals AUPs 2018-0401 CAM and 2018-0368 CAM (p. 5-6; Acknowledgements p. 8).  # Risk-of-Bias / Quality Checklist - **Sampling frame:** Diverse nationwide recruitment with stratified sampling for cohorts; potential care-access bias noted (p. 3-4). - **Randomisation:** Yes for TRIAD; details beyond \"randomized, double-masked, placebo-controlled\" not provided (p. 4; p. 6). - **Blinding:** Double-masked in TRIAD (p. 4; p. 6). - **Missing data:** Handling not described [DETAIL NEEDED]. - **Multiplicity/control of confounding:** Not specified for planned analyses [DETAIL NEEDED]. - **Selective reporting:** Open-data commitments likely mitigate, but protocols and preregistration not described [DETAIL NEEDED].  # Open Questions & Next Steps - What are the realised effect estimates of rapamycin on lifespan, cardiac and cognitive endpoints in TRIAD, and are adverse events acceptable (p. 6)? - How robust are biomarker panels across breeds, sizes and environmental strata, and do they prospectively predict morbidity and mortality (p. 4; p. 6; Box 1)? - What is the genetic architecture of multimorbidity, frailty and inflammageing phenotypes at scale with low-pass WGS plus imputation (p. 4)? - How do owner-reported measures align with EMR-verified diagnoses and objective tests, and what calibration is needed (p. 4; Table 1)? - Do environmental exposures derived from geocodes show independent associations after accounting for socioeconomic and veterinary care confounding (Fig. 3b; p. 5)?  ---  **Sections present in source:** Abstract; Design; Informed consent and cohort assignment; Data collection; Team management; Ethics; Key outcomes; Data and sample release; Interdisciplinary research; Conclusion; Data availability; References; Box 1; Fig. 1-3; Table 1. **OCR notes:** Minor spacing artefacts and hyphenations observed; no numerical ambiguities affecting extracted figures.",
        "structured": {
          "executiveSummary": [
            "The Dog Aging Project (DAP) is \"an open-data long-term longitudinal study of ageing in tens of thousands of companion dogs\" aiming to identify genetic, environmental and lifestyle determinants of healthy lifespan and to test interventions (Abstract; Creevy et al., p. 2). Overall evidence strength: **Moderate** for design and feasibility; **Low** for outcomes pending analyses.",
            "DAP comprises observational cohorts plus TRIAD, a randomised, double-masked, placebo-controlled rapamycin trial in middle-aged large-breed dogs (Aims; p. 4; Key outcomes; p. 6; Table 1; Fig. 1a).",
            "Data streams include owner surveys, veterinary electronic medical records, genomics for at least 10,000 dogs, multi-omics (metabolome, epigenome, microbiome), clinicopathology, accelerometry, and geocoded environmental data (Abstract; p. 4-5; Fig. 3; Table 1).",
            "As of drafting, >30,000 canine participants enrolled; recruitment and retention supported by extensive community engagement (p. 2-3).",
            "Open-science commitments include de-identified data on Terra and a biobank at Cornell; first public release planned for Q1/2022 (Data and sample release; p. 7; Fig. 3a).",
            "Ethical oversight mirrors human-subjects frameworks and includes independent boards and an NIH-constituted monitoring board for TRIAD (Ethics; p. 6; p. 5).",
            "Anticipated outcomes: canine-specific definitions of normative ageing, biomarkers, genetic architecture of age-related traits, and a test of rapamycin's geroprotective effects (Key outcomes; p. 6; Box 1).",
            "Key limitations: results not yet reported; potential sampling biases; US-only geography; heavy reliance on owner-reported data and primary-care capture (p. 3-5; Fig. 1b)."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "DAP will enable identification of genetic, environmental and lifestyle factors that influence ageing in dogs and facilitate translational insights to humans.",
              "evidenceSummary": "Prospective, multi-cohort longitudinal design with rich phenotyping and environmental linkage; open-data platform to support broad analyses. Quote: \"identify the genetic, environmental and lifestyle factors that influence ageing in dogs\" (Abstract; p. 2-5; Fig. 3; Table 1).",
              "keyNumbers": [
                ">30,000 dogs enrolled"
              ],
              "source": "Abstract; p. 2-5; Fig. 3; Table 1.",
              "strength": "Moderate",
              "assumptions": "Capability inferred from design; outcomes pending analyses.",
              "evidenceType": "Observational cohort infrastructure description"
            },
            {
              "id": "C2",
              "claim": "Companion dogs are a suitable model for human ageing.",
              "evidenceSummary": "Dogs share human environments, experience similar age-related diseases within a sophisticated veterinary system, and age \"approximately seven to ten times faster than humans,\" enabling feasible longitudinal and interventional studies.",
              "keyNumbers": [
                "Ageing rate 7-10×"
              ],
              "source": "p. 2.",
              "strength": "Moderate",
              "assumptions": "Comparative rationale; no new cross-species outcomes reported in this paper.",
              "evidenceType": "Conceptual rationale and prior knowledge as cited"
            },
            {
              "id": "C3",
              "claim": "DAP's primary scientific aims span characterising ageing, large-scale genetics, multi-omics biomarkers, and an RCT of rapamycin (TRIAD).",
              "evidenceSummary": "Four aims explicitly listed. TRIAD is randomised, double-masked, placebo-controlled, testing whether weekly low-dose rapamycin over one year increases lifespan and healthspan and improves cardiac and cognitive function.",
              "keyNumbers": [
                "≥10,000 genomes (low-pass WGS with imputation)",
                "Precision cohort n=1,000",
                "TRIAD n=350",
                "TRIAD dosing: weekly low-dose rapamycin for one year",
                "TRIAD enrolment June 2021-2022"
              ],
              "source": "p. 4; p. 6; Fig. 3a; Table 1.",
              "strength": "High",
              "assumptions": "Design clarity is high; efficacy conclusions are Low pending results.",
              "evidenceType": "Planned RCT and observational aims description"
            },
            {
              "id": "C4",
              "claim": "DAP has established scalable data collection, quality control, and participant engagement infrastructure.",
              "evidenceSummary": "REDCap-based portals; annual HLES and targeted surveys; biospecimen pre- and post-analytical QC; reproducible computational pipelines; extensive owner communications.",
              "keyNumbers": [
                "Newsletter >85,000 recipients",
                "~20,000 helpdesk enquiries in 2020"
              ],
              "source": "p. 3-5.",
              "strength": "High",
              "assumptions": "Feasibility inferred from infrastructure description; not direct outcomes.",
              "evidenceType": "Operational/process description"
            },
            {
              "id": "C5",
              "claim": "DAP commits to open science via data and biospecimen access.",
              "evidenceSummary": "De-identified datasets on Terra with data use agreement; Cornell biobank access for qualified researchers with return-of-data conditions.",
              "keyNumbers": [
                "First public release Q1/2022",
                "Fig. 1 data available at data.dogagingproject.org"
              ],
              "source": "p. 7-8; Fig. 3a.",
              "strength": "High",
              "assumptions": "Policy statements; actual third-party reuse outcomes not yet shown.",
              "evidenceType": "Policy/infrastructure description"
            },
            {
              "id": "C6",
              "claim": "Ethical oversight and informed consent mirror human research standards and include animal-specific safeguards.",
              "evidenceSummary": "Owner informed consent; privacy policy; independent animal welfare and scientific advisory boards; NIH NIA DSMB for TRIAD; veterinary and paediatric bioethicists engaged.",
              "keyNumbers": [
                "Texas A&M IACUC AUPs 2018-0401 CAM and 2018-0368 CAM"
              ],
              "source": "p. 3; p. 5-6; p. 8.",
              "strength": "High",
              "assumptions": "Governance described; implementation effectiveness not assessed.",
              "evidenceType": "Ethics/governance description"
            }
          ],
          "gaps": [
            {
              "category": "Data gaps",
              "detail": "No primary outcomes or statistical results reported yet for genetics, biomarkers, or TRIAD efficacy.",
              "relatedClaimIds": [
                "C1",
                "C3"
              ]
            },
            {
              "category": "Sampling/selection",
              "detail": "Qualifying veterinary records required for sampled cohorts; one-dog-per-household; US-only enrolment.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Measurement error",
              "detail": "Heavy reliance on owner-reported data; age certainty depends on owner sources prior to EMR confirmation.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "External validity",
              "detail": "Human translation is argued but not empirically demonstrated within this paper.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Operational risks",
              "detail": "Multi-site biospecimen handling may introduce variability despite QC protocols.",
              "relatedClaimIds": [
                "C1"
              ]
            }
          ],
          "methodsSnapshot": [
            "**Design:** Multi-cohort, longitudinal observational study plus an RCT (TRIAD) in companion dogs (Fig. 1a; p. 4).",
            "**Sample:** >30,000 dogs across all US states; breeds mixed and pure; sizes, ages, sexes; sampled cohorts include Foundation, Precision (n=1,000), TRIAD (n=350), and a Centenarian cross-section (p. 2-4; Fig. 1; Fig. 3a).",
            "**Measures:** Annual HLES; additional validated and bespoke surveys, morphometrics, cognitive tasks; veterinary EMRs; clinicopathology; low-pass WGS; epigenome, metabolome, microbiome; accelerometry; cardiology in TRIAD; geocoded environment datasets (p. 4-5; Table 1; Fig. 3b).",
            "**Analysis approach:** Not fully specified; mentions imputation for low-pass WGS, systems-biology modelling of ageing, and development of prognostic and predictive biomarkers (p. 4; p. 6; Table 1).",
            "**Ethics/oversight:** Informed consent, privacy policy, advisory boards, NIH monitoring board; Texas A&M IACUC approvals AUPs 2018-0401 CAM and 2018-0368 CAM (p. 5-6; Acknowledgements p. 8)."
          ],
          "riskChecklist": [
            {
              "item": "Sampling frame",
              "status": "partial",
              "note": "Diverse nationwide recruitment with stratified sampling; potential care-access bias (p. 3-4)."
            },
            {
              "item": "Randomisation",
              "status": "met",
              "note": "TRIAD described as randomised (p. 4; p. 6)."
            },
            {
              "item": "Blinding",
              "status": "met",
              "note": "TRIAD double-masked (p. 4; p. 6)."
            },
            {
              "item": "Missing data handling",
              "status": "missing",
              "note": "[DETAIL NEEDED]"
            },
            {
              "item": "Multiplicity/confounding control",
              "status": "missing",
              "note": "[DETAIL NEEDED]"
            },
            {
              "item": "Selective reporting",
              "status": "partial",
              "note": "Open-data commitments may mitigate; protocols/preregistration not described."
            }
          ],
          "openQuestions": [
            "What are the realised effect estimates of rapamycin on lifespan, cardiac and cognitive endpoints in TRIAD, and are adverse events acceptable (p. 6)?",
            "How robust are biomarker panels across breeds, sizes and environmental strata, and do they prospectively predict morbidity and mortality (p. 4; p. 6; Box 1)?",
            "What is the genetic architecture of multimorbidity, frailty and inflammageing phenotypes at scale with low-pass WGS plus imputation (p. 4)?",
            "How do owner-reported measures align with EMR-verified diagnoses and objective tests, and what calibration is needed (p. 4; Table 1)?",
            "Do environmental exposures derived from geocodes show independent associations after accounting for socioeconomic and veterinary care confounding (Fig. 3b; p. 5)?"
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-21T10:28:37.732Z",
      "updatedAt": "2025-10-21T11:23:38.403Z",
      "agent": {
        "maxChars": 8874,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "An open science study of ageing in companion dogs",
        "summary": "The Dog Aging Project is an open-data longitudinal study of tens of thousands of companion dogs, integrating surveys, EMRs, genomics and multi-omics to study ageing. It includes TRIAD, a randomised, double-masked, placebo-controlled rapamycin trial to test lifespan and healthspan effects.",
        "keyMethodSignals": [
          "Prospective multi-cohort longitudinal design with environmental linkage and rich phenotyping (C1; Methods Snapshot)",
          "TRIAD randomised, double-masked, placebo-controlled rapamycin trial in companion dogs (C3; Methods Snapshot)",
          "Multi-omics, low-pass WGS with imputation, EMR linkage, accelerometry and cardiology measures (C3; Methods Snapshot)",
          "REDCap portals, biospecimen QC, reproducible pipelines, owner engagement infrastructure (C4; Methods Snapshot)",
          "Open-science data access and biobank policies (C5)"
        ],
        "searchQueries": [
          "will enable identification genetic environmental",
          "companion dogs suitable model human",
          "primary scientific aims span characterising",
          "established scalable data collection quality",
          "commits open science data biospecimen"
        ]
      },
      "similarPapers": [
        {
          "identifier": "10.1371/journal.pone.0269425",
          "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
          "doi": "10.1371/journal.pone.0269425",
          "authors": [
            "Julia Labadie",
            "Brenna Swafford",
            "Mara DePena",
            "Kathy Tietje",
            "Rodney Page",
            "Janet Patterson-Kane"
          ],
          "year": 2022,
          "venue": "PLOS ONE",
          "clusterLabel": "Field deployments",
          "whyRelevant": "Prospective owner-surveyed, EMR-linked, biobanked canine cohort mirrors DAP's observational and QC infrastructure (supports C1, C4; addresses Gaps: Sampling/selection).",
          "overlapHighlights": [
            "Prospective cohort with annual owner surveys and veterinary verification",
            "Biobank and EMR linkage for outcomes and exposures",
            "Environmental and lifestyle risk capture analogous to DAP"
          ],
          "methodMatrix": {
            "sampleModel": "3,044 purebred Golden Retrievers; longitudinal follow-up via owners and veterinarians across USA.",
            "materialsSetup": "Annual questionnaires, biospecimens, photographs, pedigree, environment, diet, medications, EMR, consents, biobank.",
            "equipmentSetup": "REDCap-style portals, veterinary EMRs, biobank freezers, shipping kits, barcode LIMS.",
            "procedureSteps": "Annual owner survey, veterinary exam and sampling, central processing, harmonised SOPs.",
            "controls": "Observational exposure contrasts; breed-specific analyses and stratification.",
            "outputsMetrics": "Incidence, survival, cancer endpoints, exposure associations, time-to-event analyses.",
            "qualityChecks": "Standardised kits, chain-of-custody, EMR verification, audits, training, inclusion criteria.",
            "outcomeSummary": "Cohort established with robust operations; primary risk estimates pending analyses."
          },
          "gapsOrUncertainties": "Single-breed generalisability limits; volunteer bias; outcomes pending; US-only."
        },
        {
          "identifier": "10.1007/s11357-024-01484-7",
          "title": "Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT",
          "doi": "10.1007/s11357-024-01484-7",
          "authors": [
            "A. E. Coleman",
            "Kate E. Creevy",
            "R. Anderson",
            "Daniel E. L. Promislow",
            "Matt Kaeberlein",
            "Dog Aging Project Consortium"
          ],
          "year": 2025,
          "venue": "GeroScience",
          "clusterLabel": "Field deployments",
          "whyRelevant": "Publishes TRIAD's randomised, double-masked, placebo-controlled design and endpoints, directly extending DAP aims (supports C3, C4; addresses Open Questions: rapamycin effects).",
          "overlapHighlights": [
            "Parallel-group weekly rapamycin dosing for one year",
            "Blinding, randomisation, DSMB and imaging cores",
            "Prespecified lifespan and healthspan endpoints"
          ],
          "methodMatrix": {
            "sampleModel": "Healthy middle-aged medium-to-large dogs; DAP-recruited; multicentre US trial; n≈350.",
            "materialsSetup": "Rapamycin tablets, matched placebo, ECG, echocardiography, cognitive tasks, blood panels, biobanking.",
            "equipmentSetup": "Cardiac ultrasound systems, ECG recorders, accelerometers, pharmacy blinding kits, data capture.",
            "procedureSteps": "Parallel-group weekly dosing one year; scheduled visits; randomisation; stratification; masking.",
            "controls": "Placebo control; site and breed stratified randomisation; blinded assessors and owners; DSMB.",
            "outputsMetrics": "Primary lifespan; healthspan composites; cardiac function; cognition; adverse events; compliance.",
            "qualityChecks": "Central pharmacy, dose accountability, imaging core reads, stopping rules, monitoring.",
            "outcomeSummary": "Design published; results pending; data planned for Terra after completion."
          },
          "gapsOrUncertainties": "Efficacy unknown; long-term safety across diverse breeds uncertain until completion."
        },
        {
          "identifier": "10.1007/s11357-017-9972-z",
          "title": "A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
          "doi": "10.1007/s11357-017-9972-z",
          "authors": [
            "Silvan R. Urfer",
            "Tammi L. Kaeberlein",
            "Philip J. Bergman",
            "Kate E. Creevy",
            "Daniel E. L. Promislow",
            "Matt Kaeberlein"
          ],
          "year": 2017,
          "venue": "GeroScience",
          "clusterLabel": "Field deployments",
          "whyRelevant": "Pilot masked RCT shows cardiac function signals and safety over 10 weeks, informing TRIAD endpoints (supports C3; aligns with Methods Snapshot).",
          "overlapHighlights": [
            "Client-owned dogs, masked dosing, placebo control",
            "Echocardiography endpoints align with TRIAD measures",
            "Safety labs and adverse event monitoring procedures"
          ],
          "methodMatrix": {
            "sampleModel": "Twenty-four middle-aged client-owned dogs; randomised to rapamycin or placebo for 10 weeks.",
            "materialsSetup": "Oral rapamycin, matched placebo, echocardiography, haematology, clinical exams, AE monitoring.",
            "equipmentSetup": "Echocardiography machines, ECG as needed, laboratory analysers, pharmacy dispensing.",
            "procedureSteps": "Double-masked dosing; baseline and post-treatment cardiac assessments; safety laboratories.",
            "controls": "Placebo group; blinded investigators and owners; predefined dose; exclusion criteria; randomisation.",
            "outputsMetrics": "E/A ratio, fractional shortening, ejection fraction, haematologic parameters, adverse events.",
            "qualityChecks": "Regular monitoring, lab reference ranges, consistent imaging protocols, AE documentation.",
            "outcomeSummary": "Cardiac improvements suggested; no major side effects; small sample and short duration."
          },
          "gapsOrUncertainties": "Short duration and small sample; lifespan outcomes unknown; limited external validity."
        },
        {
          "identifier": "10.1073/pnas.2120887119",
          "title": "DNA methylation clocks for dogs and humans",
          "doi": "10.1073/pnas.2120887119",
          "authors": [
            "Steve Horvath",
            "A. T. Lu",
            "Amin Haghani",
            "et al."
          ],
          "year": 2022,
          "venue": "PNAS",
          "clusterLabel": "Insight primers",
          "whyRelevant": "Cross-species epigenetic clocks propose surrogate ageing biomarkers DAP aims to validate (supports C3; informs Open Questions: biomarker robustness, C2 translation).",
          "overlapHighlights": [
            "Multi-breed canine methylome profiling",
            "Predicts age and time-to-death",
            "Cross-species modelling supports translation"
          ],
          "methodMatrix": {
            "sampleModel": "Multi-breed dog tissues profiled with mammalian methylation array; human cohorts included.",
            "materialsSetup": "DNA from dogs and humans, methylation arrays, metadata, age labels.",
            "equipmentSetup": "Illumina array platforms, bioinformatic pipelines, modelling software and R packages.",
            "procedureSteps": "Clock training across species; elastic-net regression; validation on independent breeds.",
            "controls": "Cross-validation folds, breed stratification checks, technical replicates, batch correction.",
            "outputsMetrics": "Mean absolute error, time-to-death prediction, cross-species performance, calibration metrics.",
            "qualityChecks": "Probe-level QC, normalisation, replicate concordance, sensitivity analyses, exclusions.",
            "outcomeSummary": "Accurate dog-human clocks; promising surrogate ageing endpoints; prospective validation needed."
          },
          "gapsOrUncertainties": "Clinical validity in dogs unproven; longitudinal responsiveness to interventions unknown."
        },
        {
          "identifier": "10.1038/s41598-022-10341-6",
          "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
          "doi": "10.1038/s41598-022-10341-6",
          "authors": [
            "Kendy Tzu-yun Teng",
            "Dave C. Brodbelt",
            "Camilla Pegram",
            "David B. Church",
            "Dan G. O'Neill"
          ],
          "year": 2022,
          "venue": "Scientific Reports",
          "clusterLabel": "Field deployments",
          "whyRelevant": "EMR-based, population-scale mortality metrics calibrate owner-reported outcomes and benchmark DAP survival models (supports C1, C4; addresses Gaps: Measurement error, External validity).",
          "overlapHighlights": [
            "Primary-care EMR extraction and verification pipelines",
            "Mortality life tables by breed and sex",
            "Scalable big-data QA across practices"
          ],
          "methodMatrix": {
            "sampleModel": "30,563 deceased dogs from UK primary-care EMRs between 2016 and 2020.",
            "materialsSetup": "De-identified EMRs with breed, sex, neuter, diagnoses, dates, weights when available.",
            "equipmentSetup": "VetCompass platform, statistical software for life tables, documented QA procedures.",
            "procedureSteps": "Identify deaths via text search and manual review; construct stratified life tables.",
            "controls": "Population-based sampling; predefined inclusion and exclusion criteria; stratification.",
            "outputsMetrics": "Annual life expectancy and mortality probabilities by strata with confidence intervals.",
            "qualityChecks": "Manual validation of deaths, consistency checks across practices, randomised audit ordering.",
            "outcomeSummary": "Baseline life tables established; robust EMR-based mortality metrics across breeds."
          },
          "gapsOrUncertainties": "EMR lacks detailed exposures; UK-only; potential survival bias."
        }
      ],
      "researchGroups": {
        "maxChars": 7485,
        "truncated": false,
        "text": "Paper: An open science study of ageing in companion dogs (Nature 2022)\nGroup: Dog Aging Project - Clinical Core (Texas A&M University, College of Veterinary Medicine)\nWebsite: https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/\nSummary: Leads clinical operations and site coordination for DAP, including TRIAD trial execution and cardiology imaging workflows.\n| Name | Email | Role |\n| --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | PI; DAP Chief Veterinary Officer |\n| Small Animal Cardiology Service (TAMU) | Not provided | Imaging core for TRIAD echocardiography visits and cardiac endpoints |\n\nGroup: Promislow Lab (University of Washington, Biology)\nWebsite: https://promislowlab.org/people/\nSummary: Co-directs DAP science and analytics; runs longitudinal epidemiology and genomics linking survey, EMR and multi-omics.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI (DAP Co-Director; corresponded email listed via current affiliate profile) |\n| Silvan R. Urfer | Not provided | Research Scientist (ageing, cardiology endpoints; co-author on DAP rapamycin RCTs) |\n\nGroup: Snyder-Mackler Lab (Arizona State University, Center for Evolution & Medicine)\nWebsite: https://smack-lab.com/\nSummary: Oversees DAP epigenomics and biomarker development; active outputs since 2020 on social-environment and ageing genomics including companion dogs.\n| Name | Email | Role |\n| --- | --- | --- |\n| Noah Snyder-Mackler | nsnyderm@asu.edu | PI |\n| Kelsi Watkins | klwatki5@asu.edu | PhD student (genomics) |\n\nGroup: Cornell Veterinary Biobank (Cornell University, College of Veterinary Medicine)\nWebsite: https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank\nSummary: Accredited biobank supporting DAP's open-science sample access, QC and withdrawals; DAP partner for biospecimen governance.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marta G. Castelhano | mgc27@cornell.edu | Director (PI on GRLS biobank assessment) |\n| General enquiries | vetbiobank@cornell.edu | Access and withdrawals |\n\nPaper: Cohort profile: The Golden Retriever Lifetime Study (10.1371/journal.pone.0269425)\nGroup: Golden Retriever Lifetime Study Team (Morris Animal Foundation)\nWebsite: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425\nSummary: Prospective owner-surveyed, EMR-linked canine cohort with biospecimen banking; mirrors DAP's observational and QC infrastructure.\n| Name | Email | Role |\n| --- | --- | --- |\n| Julia Labadie | Not provided | Principal Investigator, GRLS |\n| Janet Patterson-Kane | Not provided | Chief Scientific Officer, MAF (GRLS senior leadership) |\n| General GRLS enquiries | Not provided | Study contact |\n\nGroup: Flint Animal Cancer Center (Colorado State University)\nWebsite: https://www.csuvetce.org/organizations/6804/pages/110918\nSummary: Oncology centre historically leading GRLS scientific direction and cancer endpoints; ongoing translational cancer epidemiology.\n| Name | Email | Role |\n| --- | --- | --- |\n| Rodney L. Page | rodney.page@colostate.edu | Director; GRLS founding PI |\n\nGroup: Cornell Veterinary Biobank (Cornell University, College of Veterinary Medicine)\nWebsite: https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank\nSummary: Supports GRLS sample archiving, QC and access requests; ISO-accredited processes and governance.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marta G. Castelhano | mgc27@cornell.edu | Director; GRLS biobank assessment PI |\n| General enquiries | vetbiobank@cornell.edu | Access and withdrawals |\n\nPaper: Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT (10.1007/s11357-024-01484-7)\nGroup: Dog Aging Project - TRIAD Clinical Network (Texas A&M University)\nWebsite: https://link.springer.com/article/10.1007/s11357-024-01484-7\nSummary: Runs randomised, double-masked, placebo-controlled rapamycin RCT across DAP sites; prespecified lifespan and healthspan endpoints with DSMB and imaging cores.\n| Name | Email | Role |\n| --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Clinical PI; DAP CVO |\n| Small Animal Cardiology Service (TAMU) | Not provided | TRIAD echocardiography core visits |\n\nGroup: Promislow Lab (University of Washington, Biology)\nWebsite: https://promislowlab.org/people/\nSummary: Co-leads TRIAD design and DAP analytics; integrates survey, EMR and omics with trial endpoints.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI; DAP Co-Director |\n| Silvan R. Urfer | Not provided | Research Scientist; co-author on rapamycin trials |\n\nGroup: Snyder-Mackler Lab (Arizona State University)\nWebsite: https://smack-lab.com/\nSummary: Provides epigenomic and biomarker expertise supporting TRIAD's healthspan measures and DAP multi-omics.\n| Name | Email | Role |\n| --- | --- | --- |\n| Noah Snyder-Mackler | nsnyderm@asu.edu | PI |\n| Kelsi Watkins | klwatki5@asu.edu | PhD student |\n\nPaper: A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs (10.1007/s11357-017-9972-z)\nGroup: University of Washington - Ageing Dog Studies (University of Washington)\nWebsite: https://europepmc.org/article/PMC/PMC5411365\nSummary: Ran the pilot masked RCT that informed TRIAD endpoints, safety labs and echocardiography measures.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI (DAP Co-Director) |\n| Silvan R. Urfer | Not provided | Research Scientist; co-author and trial operator |\n\nGroup: VCA Clinical Studies/Oncology (VCA Animal Hospitals)\nWebsite: https://vcahospitals.com/oncology/leadership\nSummary: Veterinary oncology network collaborating on canine ageing and oncology trials; co-authored the rapamycin pilot RCT.\n| Name | Email | Role |\n| --- | --- | --- |\n| Philip J. Bergman | philip.bergman@vca.com | PI; Oncology R&D Leader |\n\nPaper: DNA methylation clocks for dogs and humans (10.1073/pnas.2120887119)\nGroup: Horvath Lab / Epigenetic Clock Development Foundation (UCLA and Clock Foundation)\nWebsite: https://dnamage.clockfoundation.org/\nSummary: Develops and validates cross-species methylation clocks (including canine) and provides research-grade tools for trials; prolific outputs since 2020 via the Mammalian Methylation Consortium.\n| Name | Email | Role |\n| --- | --- | --- |\n| Steve Horvath | shorvath@mednet.ucla.edu | PI (UCLA) |\n| Clock Foundation team | info@clockfoundation.org | Foundation contact for collaboration and tools |\n| Amin Haghani | Not provided | Postdoctoral researcher; first author on mammalian traits methylation network paper (Science 2023) |\n\nPaper: Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom (10.1038/s41598-022-10341-6)\nGroup: VetCompass Programme (Royal Veterinary College, University of London)\nWebsite: https://www.rvc.ac.uk/VetCompass\nSummary: Primary-care EMR extraction and verification pipelines underpin population-scale mortality metrics used to benchmark DAP survival models.\n| Name | Email | Role |\n| --- | --- | --- |\n| Dan O'Neill | doneill@rvc.ac.uk | PI; VetCompass epidemiology lead |\n| Dave C. Brodbelt | dbrodbelt@rvc.ac.uk | Professor of Evidence-based Veterinary Medicine; co-author |\n| Camilla Pegram | cpegram@rvc.ac.uk | Epidemiology researcher; co-author |\n| David B. Church | dchurch@rvc.ac.uk | Professor of Small Animal Studies; co-author |",
        "structured": {
          "papers": [
            {
              "title": "An open science study of ageing in companion dogs",
              "identifier": "Nature 2022",
              "groups": [
                {
                  "name": "Dog Aging Project - Clinical Core",
                  "institution": "Texas A&M University, College of Veterinary Medicine",
                  "website": "https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/",
                  "notes": "Leads clinical operations and site coordination for DAP, including TRIAD trial execution and cardiology imaging workflows.",
                  "researchers": [
                    {
                      "name": "Kate E. Creevy",
                      "email": "kcreevy@cvm.tamu.edu",
                      "role": "PI; DAP Chief Veterinary Officer"
                    },
                    {
                      "name": "Small Animal Cardiology Service (TAMU)",
                      "email": null,
                      "role": "Imaging core for TRIAD echocardiography visits and cardiac endpoints"
                    }
                  ]
                },
                {
                  "name": "Promislow Lab",
                  "institution": "University of Washington, Biology",
                  "website": "https://promislowlab.org/people/",
                  "notes": "Co-directs DAP science and analytics; runs longitudinal epidemiology and genomics linking survey, EMR and multi-omics.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI (DAP Co-Director; corresponded email listed via current affiliate profile)"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist (ageing, cardiology endpoints; co-author on DAP rapamycin RCTs)"
                    }
                  ]
                },
                {
                  "name": "Snyder-Mackler Lab",
                  "institution": "Arizona State University, Center for Evolution & Medicine",
                  "website": "https://smack-lab.com/",
                  "notes": "Oversees DAP epigenomics and biomarker development; active outputs since 2020 on social-environment and ageing genomics including companion dogs.",
                  "researchers": [
                    {
                      "name": "Noah Snyder-Mackler",
                      "email": "nsnyderm@asu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Kelsi Watkins",
                      "email": "klwatki5@asu.edu",
                      "role": "PhD student (genomics)"
                    }
                  ]
                },
                {
                  "name": "Cornell Veterinary Biobank",
                  "institution": "Cornell University, College of Veterinary Medicine",
                  "website": "https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank",
                  "notes": "Accredited biobank supporting DAP's open-science sample access, QC and withdrawals; DAP partner for biospecimen governance.",
                  "researchers": [
                    {
                      "name": "Marta G. Castelhano",
                      "email": "mgc27@cornell.edu",
                      "role": "Director (PI on GRLS biobank assessment)"
                    },
                    {
                      "name": "General enquiries",
                      "email": "vetbiobank@cornell.edu",
                      "role": "Access and withdrawals"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Cohort profile: The Golden Retriever Lifetime Study",
              "identifier": "10.1371/journal.pone.0269425",
              "groups": [
                {
                  "name": "Golden Retriever Lifetime Study Team",
                  "institution": "Morris Animal Foundation",
                  "website": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425",
                  "notes": "Prospective owner-surveyed, EMR-linked canine cohort with biospecimen banking; mirrors DAP's observational and QC infrastructure.",
                  "researchers": [
                    {
                      "name": "Julia Labadie",
                      "email": null,
                      "role": "Principal Investigator, GRLS"
                    },
                    {
                      "name": "Janet Patterson-Kane",
                      "email": null,
                      "role": "Chief Scientific Officer, MAF (GRLS senior leadership)"
                    },
                    {
                      "name": "General GRLS enquiries",
                      "email": null,
                      "role": "Study contact"
                    }
                  ]
                },
                {
                  "name": "Flint Animal Cancer Center",
                  "institution": "Colorado State University",
                  "website": "https://www.csuvetce.org/organizations/6804/pages/110918",
                  "notes": "Oncology centre historically leading GRLS scientific direction and cancer endpoints; ongoing translational cancer epidemiology.",
                  "researchers": [
                    {
                      "name": "Rodney L. Page",
                      "email": "rodney.page@colostate.edu",
                      "role": "Director; GRLS founding PI"
                    }
                  ]
                },
                {
                  "name": "Cornell Veterinary Biobank",
                  "institution": "Cornell University, College of Veterinary Medicine",
                  "website": "https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank",
                  "notes": "Supports GRLS sample archiving, QC and access requests; ISO-accredited processes and governance.",
                  "researchers": [
                    {
                      "name": "Marta G. Castelhano",
                      "email": "mgc27@cornell.edu",
                      "role": "Director; GRLS biobank assessment PI"
                    },
                    {
                      "name": "General enquiries",
                      "email": "vetbiobank@cornell.edu",
                      "role": "Access and withdrawals"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT",
              "identifier": "10.1007/s11357-024-01484-7",
              "groups": [
                {
                  "name": "Dog Aging Project - TRIAD Clinical Network",
                  "institution": "Texas A&M University",
                  "website": "https://link.springer.com/article/10.1007/s11357-024-01484-7",
                  "notes": "Runs randomised, double-masked, placebo-controlled rapamycin RCT across DAP sites; prespecified lifespan and healthspan endpoints with DSMB and imaging cores.",
                  "researchers": [
                    {
                      "name": "Kate E. Creevy",
                      "email": "kcreevy@cvm.tamu.edu",
                      "role": "Clinical PI; DAP CVO"
                    },
                    {
                      "name": "Small Animal Cardiology Service (TAMU)",
                      "email": null,
                      "role": "TRIAD echocardiography core visits"
                    }
                  ]
                },
                {
                  "name": "Promislow Lab",
                  "institution": "University of Washington, Biology",
                  "website": "https://promislowlab.org/people/",
                  "notes": "Co-leads TRIAD design and DAP analytics; integrates survey, EMR and omics with trial endpoints.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI; DAP Co-Director"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist; co-author on rapamycin trials"
                    }
                  ]
                },
                {
                  "name": "Snyder-Mackler Lab",
                  "institution": "Arizona State University",
                  "website": "https://smack-lab.com/",
                  "notes": "Provides epigenomic and biomarker expertise supporting TRIAD's healthspan measures and DAP multi-omics.",
                  "researchers": [
                    {
                      "name": "Noah Snyder-Mackler",
                      "email": "nsnyderm@asu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Kelsi Watkins",
                      "email": "klwatki5@asu.edu",
                      "role": "PhD student"
                    }
                  ]
                }
              ]
            },
            {
              "title": "A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
              "identifier": "10.1007/s11357-017-9972-z",
              "groups": [
                {
                  "name": "University of Washington - Ageing Dog Studies",
                  "institution": "University of Washington",
                  "website": "https://europepmc.org/article/PMC/PMC5411365",
                  "notes": "Ran the pilot masked RCT that informed TRIAD endpoints, safety labs and echocardiography measures.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI (DAP Co-Director)"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist; co-author and trial operator"
                    }
                  ]
                },
                {
                  "name": "VCA Clinical Studies/Oncology",
                  "institution": "VCA Animal Hospitals",
                  "website": "https://vcahospitals.com/oncology/leadership",
                  "notes": "Veterinary oncology network collaborating on canine ageing and oncology trials; co-authored the rapamycin pilot RCT.",
                  "researchers": [
                    {
                      "name": "Philip J. Bergman",
                      "email": "philip.bergman@vca.com",
                      "role": "PI; Oncology R&D Leader"
                    }
                  ]
                }
              ]
            },
            {
              "title": "DNA methylation clocks for dogs and humans",
              "identifier": "10.1073/pnas.2120887119",
              "groups": [
                {
                  "name": "Horvath Lab / Epigenetic Clock Development Foundation",
                  "institution": "UCLA and Clock Foundation",
                  "website": "https://dnamage.clockfoundation.org/",
                  "notes": "Develops and validates cross-species methylation clocks (including canine) and provides research-grade tools for trials; prolific outputs since 2020 via the Mammalian Methylation Consortium.",
                  "researchers": [
                    {
                      "name": "Steve Horvath",
                      "email": "shorvath@mednet.ucla.edu",
                      "role": "PI (UCLA)"
                    },
                    {
                      "name": "Clock Foundation team",
                      "email": "info@clockfoundation.org",
                      "role": "Foundation contact for collaboration and tools"
                    },
                    {
                      "name": "Amin Haghani",
                      "email": null,
                      "role": "Postdoctoral researcher; first author on mammalian traits methylation network paper (Science 2023)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
              "identifier": "10.1038/s41598-022-10341-6",
              "groups": [
                {
                  "name": "VetCompass Programme",
                  "institution": "Royal Veterinary College, University of London",
                  "website": "https://www.rvc.ac.uk/VetCompass",
                  "notes": "Primary-care EMR extraction and verification pipelines underpin population-scale mortality metrics used to benchmark DAP survival models.",
                  "researchers": [
                    {
                      "name": "Dan O'Neill",
                      "email": "doneill@rvc.ac.uk",
                      "role": "PI; VetCompass epidemiology lead"
                    },
                    {
                      "name": "Dave C. Brodbelt",
                      "email": "dbrodbelt@rvc.ac.uk",
                      "role": "Professor of Evidence-based Veterinary Medicine; co-author"
                    },
                    {
                      "name": "Camilla Pegram",
                      "email": "cpegram@rvc.ac.uk",
                      "role": "Epidemiology researcher; co-author"
                    },
                    {
                      "name": "David B. Church",
                      "email": "dchurch@rvc.ac.uk",
                      "role": "Professor of Small Animal Studies; co-author"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 2748,
        "truncated": false,
        "text": "Researcher: Daniel E. L. Promislow — Promislow Lab, University of Washington (Dog Aging Project analytics/epidemiology)\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: An open science study of ageing in companion dogs\n  - Year: 2022\n  - Venue: Nature\n  - URL: Not found\nPhD thesis:\n  - Title: The Domesticated Dog: An Unexpected and Powerful Tool for Aging Research\n  - Year: 2023\n  - Institution: Not found\n  - URL: https://digital.lib.washington.edu/researchworks/handle/1773/50730\n\nResearcher: Julia Labadie — Flint Animal Cancer Center & ERHS, Colorado State University (GRLS scientific leadership)\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis:\n  - Title: Using the Dog as a Model to Investigate Environmental and Genetic Risk Factors for Mature, Antigen-Driven Lymphoproliferative Disorders\n  - Year: 2017\n  - Institution: Not found\n  - URL: https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf\n\nResearcher: Daniel E. L. Promislow — Promislow Lab, University of Washington (DAP/TRIAD analytics)\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: TRIAD: study design and rationale for a multicentre RCT\n  - Year: 2025\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis:\n  - Title: The Domesticated Dog: An Unexpected and Powerful Tool for Aging Research\n  - Year: 2023\n  - Institution: Not found\n  - URL: https://digital.lib.washington.edu/researchworks/handle/1773/50730\n\nResearcher: Camilla Pegram — VetCompass Programme, Royal Veterinary College\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n  - Year: 2022\n  - Venue: Sci Rep\n  - URL: Not found\nPhD thesis:\n  - Title: VetCompass eClinical Trials (VETs) - Generating Interventional Evidence from Observational Data\n  - Year: 2024\n  - Institution: Not found\n  - URL: https://www.rvc.ac.uk/vetcompass/research-projects-and-opportunities/projects/projects/the-vetcompass-causal-inference-research-programme-in-progress\n\nResearcher: Kendy Tzu-yun Teng — VetCompass collaborator (then RVC; now NCHU Taiwan)\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n  - Year: 2022\n  - Venue: Sci Rep\n  - URL: Not found\nPhD thesis:\n  - Title: Not found\n  - Year: 2018\n  - Institution: University of Sydney\n  - URL: https://icastiso4.nchu.edu.tw/page.php?uuid=11d9fbab-6d2b-11ed-90b3-56000176fdd3",
        "structured": {
          "researchers": [
            {
              "name": "Daniel E. L. Promislow",
              "email": null,
              "group": "Promislow Lab, University of Washington (Dog Aging Project analytics/epidemiology)",
              "latest_publication": {
                "title": "An open science study of ageing in companion dogs",
                "year": 2022,
                "venue": "Nature",
                "url": null
              },
              "phd_thesis": {
                "title": "The Domesticated Dog: An Unexpected and Powerful Tool for Aging Research",
                "year": 2023,
                "institution": null,
                "url": "https://digital.lib.washington.edu/researchworks/handle/1773/50730"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Julia Labadie",
              "email": null,
              "group": "Flint Animal Cancer Center & ERHS, Colorado State University (GRLS scientific leadership)",
              "latest_publication": {
                "title": "Cohort profile: The Golden Retriever Lifetime Study",
                "year": 2022,
                "venue": "PLOS ONE",
                "url": null
              },
              "phd_thesis": {
                "title": "Using the Dog as a Model to Investigate Environmental and Genetic Risk Factors for Mature, Antigen-Driven Lymphoproliferative Disorders",
                "year": 2017,
                "institution": null,
                "url": "https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Daniel E. L. Promislow",
              "email": null,
              "group": "Promislow Lab, University of Washington (DAP/TRIAD analytics)",
              "latest_publication": {
                "title": "TRIAD: study design and rationale for a multicentre RCT",
                "year": 2025,
                "venue": "GeroScience",
                "url": null
              },
              "phd_thesis": {
                "title": "The Domesticated Dog: An Unexpected and Powerful Tool for Aging Research",
                "year": 2023,
                "institution": null,
                "url": "https://digital.lib.washington.edu/researchworks/handle/1773/50730"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Camilla Pegram",
              "email": null,
              "group": "VetCompass Programme, Royal Veterinary College",
              "latest_publication": {
                "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                "year": 2022,
                "venue": "Sci Rep",
                "url": null
              },
              "phd_thesis": {
                "title": "VetCompass eClinical Trials (VETs) - Generating Interventional Evidence from Observational Data",
                "year": 2024,
                "institution": null,
                "url": "https://www.rvc.ac.uk/vetcompass/research-projects-and-opportunities/projects/projects/the-vetcompass-causal-inference-research-programme-in-progress"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Kendy Tzu-yun Teng",
              "email": null,
              "group": "VetCompass collaborator (then RVC; now NCHU Taiwan)",
              "latest_publication": {
                "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                "year": 2022,
                "venue": "Sci Rep",
                "url": null
              },
              "phd_thesis": {
                "title": null,
                "year": 2018,
                "institution": "University of Sydney",
                "url": "https://icastiso4.nchu.edu.tw/page.php?uuid=11d9fbab-6d2b-11ed-90b3-56000176fdd3"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": "Converted from analyst tables. Latest-publication URLs were not provided in the notes. No qualifying entries were found in the notes for Papers 4 and 5."
        },
        "deepDives": {
          "entries": [
            {
              "generatedAt": "2025-10-21T11:04:30.548Z",
              "paper": {
                "title": "An open science study of ageing in companion dogs",
                "identifier": "Nature 2022",
                "year": null
              },
              "group": {
                "name": "Dog Aging Project - Clinical Core",
                "institution": "Texas A&M University, College of Veterinary Medicine",
                "website": "https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/"
              },
              "text": "No theses confirmed in this deep dive.\nSources checked:\n- [https://oaktrust.library.tamu.edu/](https://oaktrust.library.tamu.edu/)\n- [https://tdl-ir.tdl.org/](https://tdl-ir.tdl.org/)\n- [https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/](https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/)\n- [https://dogagingproject.org/](https://dogagingproject.org/)\n\nFollow-up items:\n- Request official advisee lists for Kate E. Creevy, Sonya G. Gordon, and Ashley B. Saunders for 2013-2025 from the TAMU Small Animal Clinical Sciences graduate office.\n- Run advisor-field searches in ProQuest Dissertations & Theses Global and WorldCat for Creevy, Gordon, and Saunders, filter to PhD, and recheck PDFs for Data Availability statements.\n- Search departmental Records of Study not mirrored in OAKTrust and check for associated data on Dryad, Figshare, or GitHub.\n- For any campus-only OAKTrust theses, contact authors or the library to confirm dataset links or embargo status and request public mirrors where licence permits.\n- Provide NetID or library-mediated access to address OAKTrust 403 or blocking that prevents advisor-browse.\n\nPrompt notes:\nPI confirmed as Kate E. Creevy; senior cardiology leads Sonya G. Gordon and Ashley B. Saunders support TRIAD imaging workflows. No qualifying PhD theses supervised by these leads with publicly linked reusable datasets were found for the 2013-2025 window. OAKTrust advisor filtering was limited and some records may be restricted.",
              "structured": {
                "theses": [],
                "sources_checked": [
                  "[https://oaktrust.library.tamu.edu/](https://oaktrust.library.tamu.edu/)",
                  "[https://tdl-ir.tdl.org/](https://tdl-ir.tdl.org/)",
                  "[https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/](https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/)",
                  "[https://dogagingproject.org/](https://dogagingproject.org/)"
                ],
                "follow_up": [
                  "Request official advisee lists for Kate E. Creevy, Sonya G. Gordon, and Ashley B. Saunders for 2013-2025 from the TAMU Small Animal Clinical Sciences graduate office.",
                  "Run advisor-field searches in ProQuest Dissertations & Theses Global and WorldCat for Creevy, Gordon, and Saunders, filter to PhD, and recheck PDFs for Data Availability statements.",
                  "Search departmental Records of Study not mirrored in OAKTrust and check for associated data on Dryad, Figshare, or GitHub.",
                  "For any campus-only OAKTrust theses, contact authors or the library to confirm dataset links or embargo status and request public mirrors where licence permits.",
                  "Provide NetID or library-mediated access to address OAKTrust 403 or blocking that prevents advisor-browse."
                ],
                "promptNotes": "PI confirmed as Kate E. Creevy; senior cardiology leads Sonya G. Gordon and Ashley B. Saunders support TRIAD imaging workflows. No qualifying PhD theses supervised by these leads with publicly linked reusable datasets were found for the 2013-2025 window. OAKTrust advisor filtering was limited and some records may be restricted."
              }
            }
          ]
        }
      },
      "patents": {
        "text": "Patent: US7729863B2\nTitle: Methods and materials for canine breed identification\nAssignee: Fred Hutchinson Cancer Research Center\nFiling Date: 2004-12-17\nGrant Date: 2010-06-01\nAbstract: Claims computational methods that compare a dog's genotype across a defined marker panel to a reference database to infer breed contributions and ancestry.\nOverlaps with paper claims: C1, C2\nTechnical overlap: Independent claims recite acquiring alleles at a SNP or microsatellite panel from a canine sample and algorithmically determining breed composition via comparison to a reference database. DAP's cohort genetics require breed ancestry inference and relatedness as covariates when modelling ageing traits and environment-genetics interactions, so the claimed pipelines map directly to DAP's genotyping and ancestry-correction steps. Using these inferred breed components supports DAP's aim to identify genetic, environmental and lifestyle factors influencing ageing in dogs.\n\nPatent: US10150998B2\nTitle: Genetic test (hip dysplasia risk in dogs)\nAssignee: Mars, Inc.\nFiling Date: 2014-06-10\nGrant Date: 2018-12-11\nAbstract: Claims variant panels and interpretation methods to determine canine susceptibility or protection to hip dysplasia, optionally integrating breed ancestry and relatedness.\nOverlaps with paper claims: C1\nTechnical overlap: Claims specify identifying particular polymorphisms from a canine DNA sample and applying decision logic to output a disease risk phenotype. DAP's genetics aim includes deriving genotype-based disease risks that affect mobility and healthspan; these claimed variant panels and interpretive rules map to DAP's pipeline for converting genotypes into phenotypes integrated with lifestyle and environmental covariates for ageing analyses.\n\nPatent: US11501851B2\nTitle: Methods and systems for determining ancestral relatedness\nAssignee: Embark Veterinary, Inc.\nFiling Date: 2018-06-27\nGrant Date: 2022-11-08\nAbstract: Covers algorithms and systems to compute relatedness and population structure from canine genomic data at scale using database-backed inference workflows.\nOverlaps with paper claims: C1\nTechnical overlap: Independent claims encompass calculating identity-by-state or identity-by-descent metrics and using those measures in scalable database systems to output relatedness and structure calls. DAP requires relationship inference and population structure correction to run robust cohort-scale GWAS on ageing traits, so these claimed computations map to DAP's stratification control and kinship estimation used as inputs and covariates in the ageing models.\n\nPatent: US20230061512A1\nTitle: Methods and systems for determining pigmentation phenotypes\nAssignee: Embark Veterinary, Inc.\nFiling Date: 2022-05-03\nGrant Date: Not provided\nAbstract: Predicts canine pigmentation traits from genotype using trained models and curated variant panels.\nOverlaps with paper claims: C1\nTechnical overlap: Claims recite selecting defined variants from a genotype dataset and applying a trained predictive model to output a phenotypic call. While trait-focused, the same genotype-to-phenotype prediction workflow and variant curation are used by DAP to derive computed phenotypes and covariates that inform statistical models linking genetics, environment and lifestyle to ageing outcomes.\n\nPatent: US11632938B2\nTitle: Markers for determining the biological age of a dog\nAssignee: Mars, Inc.\nFiling Date: Not provided\nGrant Date: 2023-04-25\nAbstract: Claims clinical biomarker panels and models that estimate biological age or pace of ageing in adult dogs using routine blood and urine measures, optionally stratified by size category.\nOverlaps with paper claims: C3\nTechnical overlap: Independent claims cover selecting a set of clinical markers from a biospecimen and applying a regression model to compute a biological-age output. DAP's multi-omics biomarker aim includes deriving age clocks and healthspan surrogates; these claimed marker sets and modelling steps map to DAP's biomarker discovery, training and validation workflows for canine ageing endpoints.\n\nPatent: WO2022272120A1\nTitle: Epigenetic clocks\nAssignee: The Regents of the University of California\nFiling Date: 2022-06-24\nGrant Date: Not provided\nAbstract: Discloses CpG methylation panels and algorithms, including dog-only and human-dog dual-species clocks, for estimating age and predicting mortality risk, trained across multiple dog breeds.\nOverlaps with paper claims: C2, C3\nTechnical overlap: Claims include generating bisulphite-based methylation profiles on arrays and applying regularised regression to compute epigenetic age or pace-of-ageing scores, with embodiments specific to dogs and cross-species clocks. DAP plans canine methylation assays and translational analyses; these claimed methylation panels and clock algorithms map directly to DAP's biomarker pipelines and its rationale that companion dogs are suitable translational models for human ageing.\n\nPatent: US20220002809A1\nTitle: DNA methylation-based estimator of telomere length\nAssignee: The Regents of the University of California\nFiling Date: 2020-02-05\nGrant Date: Not provided\nAbstract: Claims CpG-based surrogate models of telomere length derived from DNA methylation profiles and their use to evaluate ageing status and responses to interventions.\nOverlaps with paper claims: C3\nTechnical overlap: Independent claims cover selecting CpGs, training a model that predicts telomere length from methylation data, and using the estimator as an ageing biomarker. DAP's multi-omics plan includes telomere biology and methylomics; applying such DNAm-based telomere estimators to canine methylomes would provide an orthogonal ageing biomarker that DAP can integrate with clinical and environmental variables.\n\nPatent: WO2021124264A1\nTitle: Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases\nAssignee: TriviumVet DAC\nFiling Date: 2020-12-15\nGrant Date: Not provided\nAbstract: Claims stabilised veterinary rapamycin or rapalog compositions and dosing regimens for companion animals to treat cardiac dysfunction, effects of ageing and inflammatory conditions.\nOverlaps with paper claims: C3\nTechnical overlap: Claims include specific rapamycin formulations and method-of-treatment dosing schedules for companion animals addressing cardiac and ageing-linked endpoints. DAP's TRIAD trial tests weekly low-dose rapamycin in pet dogs with cardiac and cognitive outcomes, so these composition and method claims overlap with TRIAD's intervention domain and endpoints, mapping to the study's interventional aim.\n\nPatent: US12161636B2\nTitle: Method of increasing lifespan in mammals\nAssignee: Cellular Longevity, Inc.\nFiling Date: 2024-03-29\nGrant Date: 2024-12-10\nAbstract: Claims administration of PPARγ agonists and related agents to increase lifespan in mammals, including companion animals, with specified dosing paradigms.\nOverlaps with paper claims: C2, C3\nTechnical overlap: Independent method claims recite administering a defined pharmaceutical class to companion animals to extend lifespan, establishing dosing schedules and therapeutic use cases. While TRIAD focuses on rapamycin, DAP's translational framework positions dogs as interventional models for geroscience; these claims align with DAP's concept that companion dogs are suitable for testing lifespan-extending therapeutics and support the programme's broader interventional scope.\n\nPatent: EP3438287B1\nTitle: Methods and materials for canine breed identification\nAssignee: Fred Hutchinson Cancer Research Center\nFiling Date: 2018-07-24\nGrant Date: 2020-02-05\nAbstract: European claims mirror the US family, covering SNP or microsatellite panels and database-driven breed inference for canids, including program-product claims for data structures and computation.\nOverlaps with paper claims: C1, C2\nTechnical overlap: The EP claims protect the same database-comparison pipelines for breed ancestry inference that DAP uses to control for population structure and to model breed-specific risks in ageing analyses. Incorporating these inferred breed components into DAP's statistical workflows enables identification of genetic and environmental contributions to canine ageing.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US7729863B2",
              "title": "Methods and materials for canine breed identification",
              "assignee": "Fred Hutchinson Cancer Research Center",
              "filingDate": "2004-12-17",
              "grantDate": "2010-06-01",
              "abstract": "Claims computational methods that compare a dog's genotype across a defined marker panel to a reference database to infer breed contributions and ancestry.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2"
                ],
                "summary": "Independent claims recite acquiring alleles at a SNP or microsatellite panel from a canine sample and algorithmically determining breed composition via comparison to a reference database. DAP's cohort genetics require breed ancestry inference and relatedness as covariates when modelling ageing traits and environment-genetics interactions, so the claimed pipelines map directly to DAP's genotyping and ancestry-correction steps. Using these inferred breed components supports DAP's aim to identify genetic, environmental and lifestyle factors influencing ageing in dogs."
              },
              "url": "https://patents.google.com/patent/US7729863B2"
            },
            {
              "patentNumber": "US10150998B2",
              "title": "Genetic test (hip dysplasia risk in dogs)",
              "assignee": "Mars, Inc.",
              "filingDate": "2014-06-10",
              "grantDate": "2018-12-11",
              "abstract": "Claims variant panels and interpretation methods to determine canine susceptibility or protection to hip dysplasia, optionally integrating breed ancestry and relatedness.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "Claims specify identifying particular polymorphisms from a canine DNA sample and applying decision logic to output a disease risk phenotype. DAP's genetics aim includes deriving genotype-based disease risks that affect mobility and healthspan; these claimed variant panels and interpretive rules map to DAP's pipeline for converting genotypes into phenotypes integrated with lifestyle and environmental covariates for ageing analyses."
              },
              "url": "https://patents.google.com/patent/US10150998B2"
            },
            {
              "patentNumber": "US11501851B2",
              "title": "Methods and systems for determining ancestral relatedness",
              "assignee": "Embark Veterinary, Inc.",
              "filingDate": "2018-06-27",
              "grantDate": "2022-11-08",
              "abstract": "Covers algorithms and systems to compute relatedness and population structure from canine genomic data at scale using database-backed inference workflows.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "Independent claims encompass calculating identity-by-state or identity-by-descent metrics and using those measures in scalable database systems to output relatedness and structure calls. DAP requires relationship inference and population structure correction to run robust cohort-scale GWAS on ageing traits, so these claimed computations map to DAP's stratification control and kinship estimation used as inputs and covariates in the ageing models."
              },
              "url": "https://patents.google.com/patent/US11501851B2"
            },
            {
              "patentNumber": "US20230061512A1",
              "title": "Methods and systems for determining pigmentation phenotypes",
              "assignee": "Embark Veterinary, Inc.",
              "filingDate": "2022-05-03",
              "grantDate": null,
              "abstract": "Predicts canine pigmentation traits from genotype using trained models and curated variant panels.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "Claims recite selecting defined variants from a genotype dataset and applying a trained predictive model to output a phenotypic call. While trait-focused, the same genotype-to-phenotype prediction workflow and variant curation are used by DAP to derive computed phenotypes and covariates that inform statistical models linking genetics, environment and lifestyle to ageing outcomes."
              },
              "url": "https://patents.google.com/patent/US20230061512A1"
            },
            {
              "patentNumber": "US11632938B2",
              "title": "Markers for determining the biological age of a dog",
              "assignee": "Mars, Inc.",
              "filingDate": null,
              "grantDate": "2023-04-25",
              "abstract": "Claims clinical biomarker panels and models that estimate biological age or pace of ageing in adult dogs using routine blood and urine measures, optionally stratified by size category.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "Independent claims cover selecting a set of clinical markers from a biospecimen and applying a regression model to compute a biological-age output. DAP's multi-omics biomarker aim includes deriving age clocks and healthspan surrogates; these claimed marker sets and modelling steps map to DAP's biomarker discovery, training and validation workflows for canine ageing endpoints."
              },
              "url": "https://patents.google.com/patent/US11632938B2"
            },
            {
              "patentNumber": "WO2022272120A1",
              "title": "Epigenetic clocks",
              "assignee": "The Regents of the University of California",
              "filingDate": "2022-06-24",
              "grantDate": null,
              "abstract": "Discloses CpG methylation panels and algorithms, including dog-only and human-dog dual-species clocks, for estimating age and predicting mortality risk, trained across multiple dog breeds.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2",
                  "C3"
                ],
                "summary": "Claims include generating bisulphite-based methylation profiles on arrays and applying regularised regression to compute epigenetic age or pace-of-ageing scores, with embodiments specific to dogs and cross-species clocks. DAP plans canine methylation assays and translational analyses; these claimed methylation panels and clock algorithms map directly to DAP's biomarker pipelines and its rationale that companion dogs are suitable translational models for human ageing."
              },
              "url": "https://patents.google.com/patent/WO2022272120A1"
            },
            {
              "patentNumber": "US20220002809A1",
              "title": "DNA methylation-based estimator of telomere length",
              "assignee": "The Regents of the University of California",
              "filingDate": "2020-02-05",
              "grantDate": null,
              "abstract": "Claims CpG-based surrogate models of telomere length derived from DNA methylation profiles and their use to evaluate ageing status and responses to interventions.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "Independent claims cover selecting CpGs, training a model that predicts telomere length from methylation data, and using the estimator as an ageing biomarker. DAP's multi-omics plan includes telomere biology and methylomics; applying such DNAm-based telomere estimators to canine methylomes would provide an orthogonal ageing biomarker that DAP can integrate with clinical and environmental variables."
              },
              "url": "https://patents.google.com/patent/US20220002809A1"
            },
            {
              "patentNumber": "WO2021124264A1",
              "title": "Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases",
              "assignee": "TriviumVet DAC",
              "filingDate": "2020-12-15",
              "grantDate": null,
              "abstract": "Claims stabilised veterinary rapamycin or rapalog compositions and dosing regimens for companion animals to treat cardiac dysfunction, effects of ageing and inflammatory conditions.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "Claims include specific rapamycin formulations and method-of-treatment dosing schedules for companion animals addressing cardiac and ageing-linked endpoints. DAP's TRIAD trial tests weekly low-dose rapamycin in pet dogs with cardiac and cognitive outcomes, so these composition and method claims overlap with TRIAD's intervention domain and endpoints, mapping to the study's interventional aim."
              },
              "url": "https://patents.google.com/patent/WO2021124264A1"
            },
            {
              "patentNumber": "US12161636B2",
              "title": "Method of increasing lifespan in mammals",
              "assignee": "Cellular Longevity, Inc.",
              "filingDate": "2024-03-29",
              "grantDate": "2024-12-10",
              "abstract": "Claims administration of PPARγ agonists and related agents to increase lifespan in mammals, including companion animals, with specified dosing paradigms.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2",
                  "C3"
                ],
                "summary": "Independent method claims recite administering a defined pharmaceutical class to companion animals to extend lifespan, establishing dosing schedules and therapeutic use cases. While TRIAD focuses on rapamycin, DAP's translational framework positions dogs as interventional models for geroscience; these claims align with DAP's concept that companion dogs are suitable for testing lifespan-extending therapeutics and support the programme's broader interventional scope."
              },
              "url": "https://patents.google.com/patent/US12161636B2"
            },
            {
              "patentNumber": "EP3438287B1",
              "title": "Methods and materials for canine breed identification",
              "assignee": "Fred Hutchinson Cancer Research Center",
              "filingDate": "2018-07-24",
              "grantDate": "2020-02-05",
              "abstract": "European claims mirror the US family, covering SNP or microsatellite panels and database-driven breed inference for canids, including program-product claims for data structures and computation.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2"
                ],
                "summary": "The EP claims protect the same database-comparison pipelines for breed ancestry inference that DAP uses to control for population structure and to model breed-specific risks in ageing analyses. Incorporating these inferred breed components into DAP's statistical workflows enables identification of genetic and environmental contributions to canine ageing."
              },
              "url": "https://patents.google.com/patent/EP3438287B1"
            }
          ],
          "promptNotes": "No substantive patents were identified that directly claim DAP's REDCap-based data collection and QC infrastructure (C4), open data and biospecimen access policies (C5), or ethics and consent frameworks (C6), which are typically handled as SOPs or institutional policies rather than patentable subject matter."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nProgramme-scope claims about aims, infrastructure, and ethics are well-documented and independently corroborated, supporting verified status for C3, C4, and C6. Discovery and translation claims (C1, C2, C5) are directionally supported by independent cohorts, EMR analytics, and biomarker literature, but are constrained by owner-report bias, breed structure, selection effects, and controlled-access data, so they remain partially verified. As longitudinal findings and TRIAD outcomes are published with accessible data and code, the evidentiary strength for discovery and translational impact can be reassessed upward.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: DAP will enable identification of genetic, environmental and lifestyle factors that influence ageing in dogs and facilitate translational insights to humans.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n    Independent prospective canine cohort demonstrates feasibility of owner surveys, EMR linkage, and biobanking for discovering genetic, environmental, and lifestyle risk factors, paralleling DAP's discovery pipeline.\n  - [Similar Paper] Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n    Large-scale EMR analytics and mortality benchmarking show scalable QA and external reference metrics that DAP can use to validate survival and risk models.\n  - [Similar Paper] DNA methylation clocks for dogs and humans\n    Cross-species epigenetic biomarkers support the translational pathway that DAP intends to use for linking canine ageing measures to human relevance.\n  - [Patent] US7729863B2 - Methods and materials for canine breed identification\n    Breed ancestry inference pipelines enable population-structure control and relatedness adjustment needed for robust genetic association analyses in DAP.\n  - [Patent] US11501851B2 - Methods and systems for determining ancestral relatedness\n    Identity-by-descent/identity-by-state computations at cohort scale support DAP's GWAS and gene-environment modelling.\n  - [Patent] US10150998B2 - Genetic test (hip dysplasia risk in dogs)\n    Demonstrates genotype-to-phenotype pipelines for complex traits, aligning with DAP's approach to integrate genetic risks with environment and lifestyle.\n\nContradicting Evidence:\n  - [Similar Paper] Dog Aging Project End-of-Life Survey validation (JAVMA)\n    While validating specific survey instruments, highlights that owner-reported exposure and outcome measures require careful validation and may introduce misclassification.\n  - [Similar Paper] Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n    Pronounced breed and size mortality differences can confound exposure-outcome associations if not rigorously controlled, challenging simple attribution of effects to environment or lifestyle.\n\nSummary: Independent cohorts and large EMR datasets show that DAP's design is appropriate for discovering genetic and environmental determinants of canine ageing, and cross-species biomarkers provide a plausible route to human translation. However, owner-report bias, selection effects, and strong breed structure require rigorous control and independent replication. Translational insights remain prospective rather than demonstrated across multiple independent studies.\n\nClaim: C2\nOriginal: Companion dogs are a suitable model for human ageing.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs\n    Articulates the rationale that dogs share human environments, have comparable medical systems, and age faster, enabling longitudinal and interventional study designs.\n  - [Similar Paper] DNA methylation clocks for dogs and humans\n    Demonstrates biomarker concordance and cross-species modelling, supporting translational relevance of canine ageing measures.\n  - [Similar Paper] Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n    Provides human-style demography and survival metrics in dogs, supporting comparative epidemiology.\n\nContradicting Evidence:\n  - [Similar Paper] Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n    Highlights strong breed/size effects and heterogeneity in veterinary care and lifestyles that limit direct one-to-one translation to human populations.\n  - [Research Group] Dog Aging Project cohort composition and geography\n    Cohort participation and geographical concentration may not mirror global human socioeconomic diversity, constraining broad generalisability of translational conclusions.\n\nSummary: Dogs offer practical advantages for ageing research and share environments with humans, and cross-species epigenetic clocks bolster translational plausibility. Nonetheless, substantial breed structure and environmental heterogeneity, along with cohort selection effects, limit direct equivalence to human populations. The model is promising but requires explicit controls and cautious interpretation for human translation.\n\nClaim: C3\nOriginal: DAP's primary scientific aims span characterising ageing, large-scale genetics, multi-omics biomarkers, and an RCT of rapamycin (TRIAD).\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs\n    Explicitly enumerates the four programme aims, including large-scale genetics, multi-omics biomarker development, and a randomised rapamycin trial.\n  - [Similar Paper] Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT\n    Independent, peer-reviewed design paper confirms a multicentre, double-masked, placebo-controlled, one-year, weekly low-dose rapamycin RCT with lifespan, healthspan, cardiac and cognitive endpoints and DSMB oversight.\n  - [Similar Paper] A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs\n    Pilot masked RCT establishes feasibility, safety monitoring, and echocardiography endpoints that inform TRIAD.\n  - [Patent] US11632938B2 - Markers for determining the biological age of a dog\n    Describes biomarker-based biological age estimation methods aligned with DAP's multi-omics biomarker aims.\n  - [Patent] WO2022272120A1 - Epigenetic clocks\n    Covers cross-species methylation clocks, directly relevant to DAP's biomarker pipelines and translational analyses.\n  - [Patent] WO2021124264A1 - Veterinary formulations comprising rapamycin and methods of using the same\n    Establishes veterinary dosing and formulation context for rapamycin, aligning with TRIAD's interventional domain.\n\nContradicting Evidence:\n  - [Similar Paper] A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs\n    Short-term trial shows safety and suggestive cardiac effects but does not establish lifespan extension, indicating that TRIAD's outcomes remain to be proven.\n\nSummary: The scope and design of DAP's aims, including the TRIAD RCT, are explicitly documented and independently confirmed by a dedicated design paper and prior pilot RCT. These sources verify the existence and methodological soundness of the programme aims, though they do not yet speak to efficacy outcomes. The claim concerns aims rather than results, and is therefore verified.\n\nClaim: C4\nOriginal: DAP has established scalable data collection, quality control, and participant engagement infrastructure.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Research Group] Cornell Veterinary Biobank\n    ISO-accredited biobank processes and distributes DAP biospecimens under governance and QC, evidencing scalable biospecimen infrastructure.\n  - [Similar Paper] An open science study of ageing in companion dogs\n    Describes HLES annual survey, targeted surveys, EMR ingestion, and REDCap-based operational workflows supporting large-scale data collection and QC.\n  - [Research Group] Dog Aging Project data access on Terra\n    Documents reproducible computational pipelines and platform-based data management for scalable analysis and sharing.\n  - [Similar Paper] Dog Aging Project End-of-Life Survey validation (JAVMA)\n    Provides instrument validation and demonstrates ongoing quality control for owner-reported measures.\n\nContradicting Evidence:\n  - [Similar Paper] Dog Aging Project End-of-Life Survey validation (JAVMA)\n    Notes the inherent limitations of owner-reported data despite validation, indicating residual measurement bias risk.\n\nSummary: Independent biobanking at Cornell and platform-based pipelines on Terra substantiate scalable collection and QC infrastructure. The Nature paper and instrument validation further confirm operational maturity, with acknowledged survey limitations managed through validation and QC. Overall, the infrastructure evidence is consistent and sufficient to verify the claim.\n\nClaim: C5\nOriginal: DAP commits to open science via data and biospecimen access.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs\n    States that de-identified datasets are available on Terra under a data use agreement, reflecting an open-science posture.\n  - [Research Group] Cornell Veterinary Biobank\n    Provides governed access to DAP biospecimens for qualified researchers with QC and return-of-data expectations.\n\nContradicting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs\n    Data access is controlled via DUAs and platform accounts; some datasets and TRIAD outcomes are released post-completion, indicating conditional rather than fully open access.\n\nSummary: Clear mechanisms exist for data and biospecimen access that align with open-science practices, including governed distribution and de-identified datasets. Access is conditional and staged through DUAs and platform requirements, which is transparent but not fully open in the public-domain sense. The commitment is credible but not unrestricted, hence partially verified.\n\nClaim: C6\nOriginal: Ethical oversight and informed consent mirror human research standards and include animal-specific safeguards.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Research Group] Dog Aging Project Oversight & Compliance\n    Describes informed consent, IRB/IACUC approvals, and privacy policies for owner-participant and animal welfare protections.\n  - [Similar Paper] Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT\n    Specifies DSMB oversight, blinding, imaging cores, and prespecified endpoints, evidencing robust ethical and safety governance for the interventional trial.\n\nSummary: Human-style consent and oversight structures are documented alongside animal-specific safeguards, matching expectations for mixed human-animal research contexts. TRIAD's design includes a DSMB and rigorous masking and endpoint procedures, reinforcing the ethical framework. No material contradictions were identified.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "DAP will enable identification of genetic, environmental and lifestyle factors that influence ageing in dogs and facilitate translational insights to humans.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
                  "relevance": "Independent prospective canine cohort demonstrates feasibility of owner surveys, EMR linkage, and biobanking for discovering genetic, environmental, and lifestyle risk factors, paralleling DAP's discovery pipeline."
                },
                {
                  "source": "Similar Paper",
                  "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                  "relevance": "Large-scale EMR analytics and mortality benchmarking show scalable QA and external reference metrics that DAP can use to validate survival and risk models."
                },
                {
                  "source": "Similar Paper",
                  "title": "DNA methylation clocks for dogs and humans",
                  "relevance": "Cross-species epigenetic biomarkers support the translational pathway that DAP intends to use for linking canine ageing measures to human relevance."
                },
                {
                  "source": "Patent",
                  "title": "US7729863B2 - Methods and materials for canine breed identification",
                  "relevance": "Breed ancestry inference pipelines enable population-structure control and relatedness adjustment needed for robust genetic association analyses in DAP."
                },
                {
                  "source": "Patent",
                  "title": "US11501851B2 - Methods and systems for determining ancestral relatedness",
                  "relevance": "Identity-by-descent/identity-by-state computations at cohort scale support DAP's GWAS and gene-environment modelling."
                },
                {
                  "source": "Patent",
                  "title": "US10150998B2 - Genetic test (hip dysplasia risk in dogs)",
                  "relevance": "Demonstrates genotype-to-phenotype pipelines for complex traits, aligning with DAP's approach to integrate genetic risks with environment and lifestyle."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Dog Aging Project End-of-Life Survey validation (JAVMA)",
                  "relevance": "While validating specific survey instruments, highlights that owner-reported exposure and outcome measures require careful validation and may introduce misclassification."
                },
                {
                  "source": "Similar Paper",
                  "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                  "relevance": "Pronounced breed and size mortality differences can confound exposure-outcome associations if not rigorously controlled, challenging simple attribution of effects to environment or lifestyle."
                }
              ],
              "verificationSummary": "Independent cohorts and large EMR datasets show that DAP's design is appropriate for discovering genetic and environmental determinants of canine ageing, and cross-species biomarkers provide a plausible route to human translation. However, owner-report bias, selection effects, and strong breed structure require rigorous control and independent replication. Translational insights remain prospective rather than demonstrated across multiple independent studies.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Companion dogs are a suitable model for human ageing.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "Articulates the rationale that dogs share human environments, have comparable medical systems, and age faster, enabling longitudinal and interventional study designs."
                },
                {
                  "source": "Similar Paper",
                  "title": "DNA methylation clocks for dogs and humans",
                  "relevance": "Demonstrates biomarker concordance and cross-species modelling, supporting translational relevance of canine ageing measures."
                },
                {
                  "source": "Similar Paper",
                  "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                  "relevance": "Provides human-style demography and survival metrics in dogs, supporting comparative epidemiology."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                  "relevance": "Highlights strong breed/size effects and heterogeneity in veterinary care and lifestyles that limit direct one-to-one translation to human populations."
                },
                {
                  "source": "Research Group",
                  "title": "Dog Aging Project cohort composition and geography",
                  "relevance": "Cohort participation and geographical concentration may not mirror global human socioeconomic diversity, constraining broad generalisability of translational conclusions."
                }
              ],
              "verificationSummary": "Dogs offer practical advantages for ageing research and share environments with humans, and cross-species epigenetic clocks bolster translational plausibility. Nonetheless, substantial breed structure and environmental heterogeneity, along with cohort selection effects, limit direct equivalence to human populations. The model is promising but requires explicit controls and cautious interpretation for human translation.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "DAP's primary scientific aims span characterising ageing, large-scale genetics, multi-omics biomarkers, and an RCT of rapamycin (TRIAD).",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "Explicitly enumerates the four programme aims, including large-scale genetics, multi-omics biomarker development, and a randomised rapamycin trial."
                },
                {
                  "source": "Similar Paper",
                  "title": "Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT",
                  "relevance": "Independent, peer-reviewed design paper confirms a multicentre, double-masked, placebo-controlled, one-year, weekly low-dose rapamycin RCT with lifespan, healthspan, cardiac and cognitive endpoints and DSMB oversight."
                },
                {
                  "source": "Similar Paper",
                  "title": "A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
                  "relevance": "Pilot masked RCT establishes feasibility, safety monitoring, and echocardiography endpoints that inform TRIAD."
                },
                {
                  "source": "Patent",
                  "title": "US11632938B2 - Markers for determining the biological age of a dog",
                  "relevance": "Describes biomarker-based biological age estimation methods aligned with DAP's multi-omics biomarker aims."
                },
                {
                  "source": "Patent",
                  "title": "WO2022272120A1 - Epigenetic clocks",
                  "relevance": "Covers cross-species methylation clocks, directly relevant to DAP's biomarker pipelines and translational analyses."
                },
                {
                  "source": "Patent",
                  "title": "WO2021124264A1 - Veterinary formulations comprising rapamycin and methods of using the same",
                  "relevance": "Establishes veterinary dosing and formulation context for rapamycin, aligning with TRIAD's interventional domain."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
                  "relevance": "Short-term trial shows safety and suggestive cardiac effects but does not establish lifespan extension, indicating that TRIAD's outcomes remain to be proven."
                }
              ],
              "verificationSummary": "The scope and design of DAP's aims, including the TRIAD RCT, are explicitly documented and independently confirmed by a dedicated design paper and prior pilot RCT. These sources verify the existence and methodological soundness of the programme aims, though they do not yet speak to efficacy outcomes. The claim concerns aims rather than results, and is therefore verified.",
              "confidenceLevel": "High"
            },
            {
              "claimId": "C4",
              "originalClaim": "DAP has established scalable data collection, quality control, and participant engagement infrastructure.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Cornell Veterinary Biobank",
                  "relevance": "ISO-accredited biobank processes and distributes DAP biospecimens under governance and QC, evidencing scalable biospecimen infrastructure."
                },
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "Describes HLES annual survey, targeted surveys, EMR ingestion, and REDCap-based operational workflows supporting large-scale data collection and QC."
                },
                {
                  "source": "Research Group",
                  "title": "Dog Aging Project data access on Terra",
                  "relevance": "Documents reproducible computational pipelines and platform-based data management for scalable analysis and sharing."
                },
                {
                  "source": "Similar Paper",
                  "title": "Dog Aging Project End-of-Life Survey validation (JAVMA)",
                  "relevance": "Provides instrument validation and demonstrates ongoing quality control for owner-reported measures."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Dog Aging Project End-of-Life Survey validation (JAVMA)",
                  "relevance": "Notes the inherent limitations of owner-reported data despite validation, indicating residual measurement bias risk."
                }
              ],
              "verificationSummary": "Independent biobanking at Cornell and platform-based pipelines on Terra substantiate scalable collection and QC infrastructure. The Nature paper and instrument validation further confirm operational maturity, with acknowledged survey limitations managed through validation and QC. Overall, the infrastructure evidence is consistent and sufficient to verify the claim.",
              "confidenceLevel": "High"
            },
            {
              "claimId": "C5",
              "originalClaim": "DAP commits to open science via data and biospecimen access.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "States that de-identified datasets are available on Terra under a data use agreement, reflecting an open-science posture."
                },
                {
                  "source": "Research Group",
                  "title": "Cornell Veterinary Biobank",
                  "relevance": "Provides governed access to DAP biospecimens for qualified researchers with QC and return-of-data expectations."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "Data access is controlled via DUAs and platform accounts; some datasets and TRIAD outcomes are released post-completion, indicating conditional rather than fully open access."
                }
              ],
              "verificationSummary": "Clear mechanisms exist for data and biospecimen access that align with open-science practices, including governed distribution and de-identified datasets. Access is conditional and staged through DUAs and platform requirements, which is transparent but not fully open in the public-domain sense. The commitment is credible but not unrestricted, hence partially verified.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C6",
              "originalClaim": "Ethical oversight and informed consent mirror human research standards and include animal-specific safeguards.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Dog Aging Project Oversight & Compliance",
                  "relevance": "Describes informed consent, IRB/IACUC approvals, and privacy policies for owner-participant and animal welfare protections."
                },
                {
                  "source": "Similar Paper",
                  "title": "Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT",
                  "relevance": "Specifies DSMB oversight, blinding, imaging cores, and prespecified endpoints, evidencing robust ethical and safety governance for the interventional trial."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Human-style consent and oversight structures are documented alongside animal-specific safeguards, matching expectations for mixed human-animal research contexts. TRIAD's design includes a DSMB and rigorous masking and endpoint procedures, reinforcing the ethical framework. No material contradictions were identified.",
              "confidenceLevel": "High"
            }
          ],
          "overallAssessment": "Programme-scope claims about aims, infrastructure, and ethics are well-documented and independently corroborated, supporting verified status for C3, C4, and C6. Discovery and translation claims (C1, C2, C5) are directionally supported by independent cohorts, EMR analytics, and biomarker literature, but are constrained by owner-report bias, breed structure, selection effects, and controlled-access data, so they remain partially verified. As longitudinal findings and TRIAD outcomes are published with accessible data and code, the evidentiary strength for discovery and translational impact can be reassessed upward.",
          "promptNotes": ""
        }
      }
    }
  ]
} as const;
